US20130177922A1 - Methods and apparatus for treating samples with acoustic energy - Google Patents
Methods and apparatus for treating samples with acoustic energy Download PDFInfo
- Publication number
- US20130177922A1 US20130177922A1 US13/711,807 US201213711807A US2013177922A1 US 20130177922 A1 US20130177922 A1 US 20130177922A1 US 201213711807 A US201213711807 A US 201213711807A US 2013177922 A1 US2013177922 A1 US 2013177922A1
- Authority
- US
- United States
- Prior art keywords
- sample
- vessel
- acoustic energy
- treatment
- acoustic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 75
- 239000012530 fluid Substances 0.000 claims description 36
- 238000012545 processing Methods 0.000 claims description 28
- 239000003570 air Substances 0.000 claims description 16
- 238000007789 sealing Methods 0.000 claims description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 229910052786 argon Inorganic materials 0.000 claims description 4
- 230000001939 inductive effect Effects 0.000 claims description 4
- 239000001307 helium Substances 0.000 claims description 2
- 229910052734 helium Inorganic materials 0.000 claims description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 2
- 239000011261 inert gas Substances 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 124
- 239000000523 sample Substances 0.000 description 263
- 230000008569 process Effects 0.000 description 41
- 239000000463 material Substances 0.000 description 31
- 108020004414 DNA Proteins 0.000 description 20
- 230000015654 memory Effects 0.000 description 20
- 239000012634 fragment Substances 0.000 description 15
- 239000002245 particle Substances 0.000 description 15
- 239000011521 glass Substances 0.000 description 14
- 239000007787 solid Substances 0.000 description 13
- 238000002835 absorbance Methods 0.000 description 12
- 229920001971 elastomer Polymers 0.000 description 12
- 239000007789 gas Substances 0.000 description 12
- 230000007246 mechanism Effects 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 239000005060 rubber Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000002156 mixing Methods 0.000 description 11
- 239000004033 plastic Substances 0.000 description 11
- 229920003023 plastic Polymers 0.000 description 11
- -1 for example Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 230000008878 coupling Effects 0.000 description 9
- 238000010168 coupling process Methods 0.000 description 9
- 238000005859 coupling reaction Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 239000003973 paint Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 101100493706 Caenorhabditis elegans bath-38 gene Proteins 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000002985 plastic film Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000009210 therapy by ultrasound Methods 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000010336 energy treatment Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
- 230000005499 meniscus Effects 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000000527 sonication Methods 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920006255 plastic film Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 238000002731 protein assay Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000011343 solid material Substances 0.000 description 3
- 230000003381 solubilizing effect Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 229920002799 BoPET Polymers 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 239000005041 Mylar™ Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000004323 axial length Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 229920001342 Bakelite® Polymers 0.000 description 1
- 101100165186 Caenorhabditis elegans bath-34 gene Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 239000005388 borosilicate glass Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005112 continuous flow technique Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 108010056929 lyticase Proteins 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000003913 materials processing Methods 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000020166 milkshake Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 238000009659 non-destructive testing Methods 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002109 single walled nanotube Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 238000007666 vacuum forming Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
- B01F31/80—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations
- B01F31/87—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations transmitting the vibratory energy by means of a fluid, e.g. by means of air shock waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
- C01B25/327—After-treatment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F2215/00—Auxiliary or complementary information in relation with mixing
- B01F2215/04—Technical information in relation with mixing
- B01F2215/0413—Numerical information
- B01F2215/0436—Operational information
- B01F2215/0454—Numerical frequency values
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00479—Means for mixing reactants or products in the reaction vessels
- B01J2219/00484—Means for mixing reactants or products in the reaction vessels by shaking, vibrating or oscillating of the reaction vessels
- B01J2219/00486—Means for mixing reactants or products in the reaction vessels by shaking, vibrating or oscillating of the reaction vessels by sonication or ultrasonication
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L99/00—Subject matter not provided for in other groups of this subclass
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/286—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
- G01N2001/2866—Grinding or homogeneising
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N2035/00465—Separating and mixing arrangements
- G01N2035/00534—Mixing by a special element, e.g. stirrer
- G01N2035/00554—Mixing by a special element, e.g. stirrer using ultrasound
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Definitions
- the invention generally relates to the field of controlled acoustic energy-emitting devices for treating biological and/or chemical material, and more particularly to performing such treatment in a laboratory or benchtop setting.
- Ultrasonics have been utilized for many years in a variety of diagnostic, therapeutic, and research purposes. Some uses of ultrasonic or acoustic energy in materials processing include breaking up and/or mixing of fluid suspensions of materials. Additional uses are in solubilizing or otherwise ensuring that all or substantially all of the constituents of a sample are in solution and/or in suspension. Regardless of the particular use, sample materials are typically contained in a plastic or glass enclosure, such as vials, tubes, culture plates/well, or micro-titer plates, with an acoustic transducer coupled to the sample by way of a coupling medium, such as water. Typically, systems in which acoustic energy is precisely controlled and transferred to a sample in a vessel are relatively low power.
- low power systems examples include high-frequency, low-intensity focused acoustic dispensing systems, which transfer droplets of sample from a fluid-air interface through an air gap to a receiving vessel, and high-frequency focused interrogation systems commonly used in non-destructive testing of materials.
- acoustic transducers can be directly immersed in the material to be treated. This type of system, in which an acoustic transducer directly contacts the sample, is capable of relatively high power; however, it is typically of lower frequency.
- a distinct disadvantage of lower frequency systems is the lack of control inherent with long wavelength acoustics.
- the low-frequency probe-type sonicator typically used in biological and chemical laboratories is operated at approximately 15 KHz, which results in wavelengths in aqueous media measuring several centimeters.
- Other systems can implement both high-power and high-control processing of diverse samples.
- there exists a need for a system with both high-power and high-control which is easy to use on a routine basis with minimal a priori sample preparation, process optimization, or operator training.
- the invention provides methods and systems for selectively exposing a sample or samples to acoustic energy in a benchtop or laboratory setting for the purpose of, for example, heating, fluidizing, mixing, stirring, disrupting, comminuting, sterilizing, or solubilizing the sample, or for enhancing a reaction in the sample.
- a sample or samples to acoustic energy in a benchtop or laboratory setting for the purpose of, for example, heating, fluidizing, mixing, stirring, disrupting, comminuting, sterilizing, or solubilizing the sample, or for enhancing a reaction in the sample.
- the foregoing applications are merely illustrative, and one skilled in the art will recognize other uses for the application of focused acoustic energy.
- Altering the sample in a controlled manner, especially biological and chemical samples allows manipulation of the sample while preserving the viability, chemical and/or biological activity of the material.
- Samples may comprise one or more constituents such as, for example, solvents, reagents, nucleic acids, proteins, small organic or inorganic molecules, chemical compounds, or pharmaceutical or biopharmaceutical agents.
- Non-clinical samples may also advantageously be treated by acoustic energy.
- a sample to be processed with acoustic energy may be physically isolated in a vessel from the surrounding environment and an acoustic energy source (e.g., transducer) which applies acoustic energy to the sample.
- the acoustic energy may be applied to the sample through a coupling medium such as water.
- acoustic energy refers to acoustic energy, acoustic waves, acoustic pulses, including forms of ultrasonic energy and/or shock waves.
- sonic energy/acoustic energy refers to the focused, high frequency (e.g., typically 100 kHz-100 MHz; greater than 500 kHz; greater than or approximately equal to 1 MHz; etc), short wavelength (e.g., approximately 1-1.5 mm), acoustic energy.
- focal zone or focal point means an area where sonic energy converges and/or impinges on a target, although that area of convergence is not necessarily a single focused point.
- the present invention provides an acoustic energy source that provides a focused acoustic field.
- the acoustic energy source can be a focused transducer having a focal length, which generates an ellipsoidal focal zone.
- the focused transducer may be spherical, ellipsoidal, cylindrical, or any other suitable shape.
- the acoustic focal length of the focused transducer may be any suitable length, e.g., from 0.1-65 mm or more in diameter.
- the focal zone resulting from the focused transducer may be between 0.1 millimeter and 2 centimeters in diameter, e.g., between 0.1 mm and 100 mm, or between 0.1 nun and 10 mm, and the axial length of the focal zone may be between 0.1 millimeter and 6 centimeters, for example, depending on the size of the sample vessel.
- the present invention provides a benchtop apparatus that can treat a sample effectively with little input from a user.
- the apparatus may also offer the user varying degrees of control over the treatment applied to the sample.
- an apparatus of the invention may feature one or more components such as a user interface for communicating with the user or an easily accessed chamber for holding the sample.
- an apparatus of the invention may include an interchangeable memory component for storing treatment protocols.
- Interchangeable memory components can include memory cards, flash drives, CDs, DVDs, CD-ROMs, diskettes, chips, and any other suitable memory storage device.
- Treatment protocols may be preprogrammed, adjust to inputs from the user, adjust to measured changes in the sample during the treatment process, be based on initial conditions or characteristics of the sample, and/or be configured manually by the user. Operation of the apparatus can be at least partially automated. Steps that may be automated include selecting treatment parameters, selecting a treatment protocol, initiating acoustic treatment, and monitoring of sample parameters during treatment.
- the acoustic energy delivered to the sample may be adjusted by the controller according to the volume of the sample, the sample temperature, and/or based on the type or concentration of particulate matter in the sample, for the purpose of, for example, comminuting the particles.
- the sensors may include temperature sensors, pressure sensors, optical sensors, such as infrared sensor, microscopes and/or video cameras, lasers, acoustic sensors such as electromagnetic or piezoelectric sensors, or a combination of such sensors.
- the sensors may be arranged coaxially or at an angle to each other.
- the sensors may be employed for measuring a physical characteristic of one or more samples before, during and/or following acoustic treatment of the samples.
- the results of the measured characteristic can be stored for use in subsequent processing steps or to compile a treatment history for the sample(s). For example, samples may be selected for further processing or interchanged for other samples based on their previously measured characteristics, or samples may be grouped and/or classified based on treatment history.
- a characteristic measured post-treatment can be assessed by itself or can be compared to the characteristic measured pre-treatment and used to determine whether a desired condition of the sample has been reached and/or to assign a subsequent treatment or processing step for the sample.
- the samples may be coupled to the acoustic energy source by a liquid, semi-solid or solid medium.
- the acoustic transducer may be placed in a tray surrounded by a fluid with a high transmissivity for the acoustic energy, and the semi-solid or solid layer may be placed between the fluid and the sample to prevent direct contact between the sample and the fluid.
- the semi-solid or solid layer may be made of silicone gel, elastomeric polyurethane, thermoplastic elastomer and the like, and may also have an additional cover layer to further protect the sample from contamination.
- pressure may be applied to the sample or to the medium transmitting the acoustic energy, for example, by pressurizing the fluid, to improve acoustic coupling between the acoustic energy source and the sample.
- the isolated sample inside a vessel may be pressurized relative to standard atmospheric pressure (e.g., to 2, 3, 4, or more •atmospheres of pressure) to improve sample processing.
- standard atmospheric pressure e.g., to 2, 3, 4, or more •atmospheres of pressure
- the desired result may be obtained in a shorter time period and/or, in some applications, may also result in improved sample processing and output quality (e.g., a narrower size distribution in a sheared DNA strand population).
- FIG. 1A depicts an exterior view of a benchtop apparatus for processing a sample according to an embodiment of the invention
- FIG. 1B depicts a cross-sectional view of the interior of a benchtop apparatus for processing a single sample according to an embodiment of the invention
- FIG. 2 is a schematic illustration of one embodiment of the apparatus according to an embodiment of the invention.
- FIG. 3 is a schematic illustration of one embodiment of a control system according to an embodiment of the invention.
- FIGS. 4A-4D depict an illustrative process for treating a pressurized sample with acoustic energy according to an embodiment of the invention
- FIGS. 5A-5D depict an illustrative process for treating a pressurized sample with acoustic energy according to an embodiment of the invention
- FIGS. 6A-6C depict an illustrative process for treating a pressurized sample with acoustic energy according to an embodiment of the invention
- FIG. 7 depicts an illustrative pressurizing device according to an embodiment of the invention.
- FIG. 8 depicts an illustrative vessel according to an embodiment of the invention.
- FIG. 9 depicts an illustrative vessel according to an embodiment of the invention.
- FIG. 10 depicts a graph of the absorbance of yeast samples after treatment at various durations, pressures, and acoustic intensities.
- FIGS. 1A and 1B depict, respectively, an exterior view and an interior cross-sectional view of a benchtop ultrasonicator 10 for processing a sample 14 according to an embodiment of the invention.
- the ultrasonicator 10 is adapted for use by a single operator, and is generally sized to fit on and be supported by a table or bench in a laboratory setting.
- the ultrasonicator 10 can have a user interface 16 disposed on an outer housing 18 , which can include a cover 12 , or other access mechanism, for accessing the interior of the ultrasonicator 10 .
- the access mechanism may allow access to a chamber within the outer housing 18 .
- the operator can access the ultrasonicator 10 by opening the cover 12 .
- the cover 12 may open by detaching from the outer housing 18 , by tilting on a hinge that attaches one side of the cover 12 to the outer housing 18 , by sliding laterally along grooves that engage the cover 12 on the outer housing 18 , by rotating in a lateral direction along a joint that attaches a corner of the cover 12 to the outer housing 18 , or any other suitable mechanism.
- the mechanism may include one or more buttons, tabs, handles, latches, or catches that may be depressed, pulled, toggled, engaged/disengaged, or rotated to open and/or close the cover 12 .
- the ultrasonicator 10 may be remotely controlled.
- a USB or RS232 connector may link the ultrasonicator 10 to a robotic system that may, for example, use ActiveX control or any other suitable control protocol.
- the cover 12 may, for example, be disposed on the outer surface of the housing, or may be disposed in a recess within the housing 18 .
- the mechanisms may be at least partially controlled electronically, such that the operator pushes a button on the user interface 16 or elsewhere on the outer housing 18 to open and/or close the cover 12 .
- ultrasonicator 10 is depicted with the cover 12 being disposed on its top surface, one of skill in the art will recognize that other embodiments may additionally or instead have a door or cover 12 on a side of the outer housing 18 , a drawer that slides laterally from the outer housing 18 , or any other suitable mechanism for accessing the interior of the ultrasonicator 10 .
- the ultrasonicator 10 may include a latch or other means for securing the cover 12 in a closed position during operation of the ultrasonicator 10 .
- the ultrasonicator 10 may include a safety mechanism such that the device will not operate when the cover 12 is in an open position.
- the cover 12 in a closed position forms an airtight seal with the outer housing 18 , to permit pressurization of the treatment chamber relative to the surrounding atmosphere.
- the cover 12 may be made of the same material as the outer housing 18 , which can be made of any suitable material, such as plastic, glass, metal, etc.
- the interior of the cover may be lined with soundproofing material capable of dampening acoustic energy so as to reduce danger, disruption, or annoyance to the operator, e.g., to allow the device to operate quietly or silently in the perception of the user.
- the soundproofing material may be configured to absorb any acoustic energy that reaches it, or to reflect the acoustic energy back towards the sample 14 .
- the outer housing 18 can be between about 5 centimeters and about 30 centimeters in width, height, or length.
- a ultrasonicator 10 may include a sensor 20 on the outer housing 18 that triggers the cover 12 to open.
- the sensor 20 may be placed on the upper portion 22 of the outer housing 18 , or any other suitable location, preferably selected to avoid accidental activation.
- the sensor 20 may include a motion detector configured to detect motion within a predetermined range, such as about 5 inches, so that the operator may move his/her hand or a sample 14 over the sensor 20 to trigger the cover 12 , but motion further from the ultrasonicator 10 would not trigger the cover 12 .
- the senor 20 may be configured to detect information about the sample 14 .
- the sample 14 could be labeled with a radio frequency identification (RFID) tag, text, a barcode, a symbol, or any other type of identifying mark, which sensor 20 could recognize using an RFID interrogator, optical recognition, acoustic recognition, or any other suitable means.
- RFID radio frequency identification
- the sample 14 could be marked using a special ink, a reflective material, or other distinguishing features that could be recognized using sensor 20 .
- sample holder 24 Upon accessing the ultrasonicator 10 , the operator may place the sample 14 within a sample holder 24 adapted to hold a sample vessel 26 containing the sample 14 .
- Suitable sample vessels 26 include tubes, vials, aerosol vials, flasks, jars, bottles, wells, arrays, blister packs, ampoules, pouches, bags, envelopes, and other containers that are manipulable by the operator and capable of containing a sample under sonication conditions.
- the sample holder 24 can be a concavity or depression having a shape similar to an outer surface of the sample vessel 26 , such that the sample vessel 26 can nest within the concavity or depression.
- the sample holder 24 can include a clamp, clip, or any other suitable fastener capable of holding the sample vessel 26 in place, e.g., around the neck of a flask or bottle, or around the body of a jar or tube.
- the sample holder 24 may also be configured to detect information about the sample 14 .
- an adjustable clamp can encircle a test tube to both hold the test tube in place and measure the circumference of the test tube.
- a concavity or depression can be equipped with a scale to weigh the sample vessel 26 and sample 14 .
- the ultrasonicator 10 may have other sensors or interrogation systems capable of detecting characteristics of the sample 14 .
- the ultrasonicator 10 may detect an identifying mark, the location of the sample vessel 26 , the level of fluid in the sample vessel 26 , or any other initial characteristics of the sample 14 . Other suitable characteristics and sensors are discussed in more detail below in reference to FIG. 2 .
- the ultrasonicator 10 may also include a safety mechanism for determining that the sample 14 has been appropriately and securely positioned in the sample holder 24 , such that the ultrasonicator 10 will not operate unless the sample 14 is appropriately and securely positioned.
- the user may close the cover 12 manually.
- the ultrasonicator 10 may automatically close the cover 12 , e.g., when the user activates the ultrasonicator 10 and/or when the ultrasonicator 10 determines that the sample is ready for sonication.
- the ultrasonicator 10 may also automatically devise and then execute a treatment protocol for the sample 14 , or may prompt the operator to select or devise a treatment protocol using the user interface 16 .
- the ultrasonicator 10 may also signal when the treatment protocol is finished, for example, by emitting an audio signal, turning an indicator light on or off, flashing or displaying a message on the user interface 16 , or re-opening the cover 12 .
- the user can use the user interface 16 to communicate with a control system of the ultrasonicator 10 which controls the operation of the ultrasonicator 10 .
- the user interface 16 can query the user for input that may be communicated to a processor of the control system.
- the user interface 16 can include a display 16 a to communicate information such as which treatment process options are available, the value of a particular setting, or data detected by any sensors the ultrasonicator 10 may have.
- the user interface 16 may also have buttons, dials, touchpads, knobs, sliders, or any other suitable control interfaces 16 b with which an operator may indicate preferences, instructions, or parameters to the ultrasonicator 10 .
- the control system automatically devises and executes a treatment protocol upon detecting the presence of a sample 14 properly disposed within the ultrasonicator 10 and/or other sample characteristics, including any identifying marks.
- the user interface 16 prompts the operator to input information that the control system can use to select a treatment protocol.
- the operator can manually configure a treatment protocol, for instance by selecting which waveform(s) to use, the duty cycle, the total energy, the relative positioning of the sample 14 to a acoustic energy source, and/or any other treatment parameters.
- the operator can select a treatment protocol from a set of preprogrammed treatment protocols.
- the preprogrammed treatment protocols can be configured to each achieve a different objective or desired result, such as sterilization, mixing, reaction enhancement, and any other application of acoustic treatment.
- Each preprogrammed treatment protocol can also be configured to correspond to a particular sample, where the control system uses the characteristics of a particular sample either detected by sensors of the ultrasonicator 10 or from information entered by the operator via the user interface 16 .
- the operator can input information about the sample, such as the sample size, sample vessel, and desired objective or result, and then the control system automatically selects and executes a treatment protocol based on the information from the operator.
- the operator may also input acceptable ranges for any measured sample characteristics or parameters, such as temperature and pressure, which can help guide the control system's selection of a treatment protocol.
- the operator can adjust the treatment protocol during the treatment process, for instance by lowering or raising the duty cycle, modifying the waveform, and/or switching to a different treatment protocol.
- the operator may also designate whether or not the treatment protocol should feedback information about the sample from sensors during the treatment process to adjust the treatment protocol.
- the control system can make feedback adjustments according to instructions from a preprogrammed treatment protocol and/or input from the operator. Further information about the control system is described below in reference to FIG. 3 .
- the user interface 16 can have an input mechanism that when activated initiates application of a focused acoustic field provided by the acoustic energy source to the sample 14 .
- the user interface 16 can have a pulse button that initiates sonication when the pulse button is pressed and stops sonication, for example, when the pulse button is released or pressed a second time.
- the parameters of the acoustic treatment can be preset by either the control system or the operator to a default treatment process, or may be selected by the operator at each use.
- the user interface 16 can have multiple pulse buttons, each corresponding to a different application, sample size, and/or treatment protocol.
- the user interface 16 can Impart information to the operator, such as which treatment protocols and/or operating modes (e.g., feedback mode, fully automatic mode, etc.) are available to the operator.
- the user interface 16 can also display information measured, detected, or recognized by any sensors of the ultrasonicator 10 , such as a sample ID from an identifying mark, sample temperature, or sample size. Information from sensors can be continuously displayed and updated during a treatment process to allow the operator to monitor the progression of the process.
- the control system may save the monitored data for later use or review by the operator.
- the saved data may be stored on a removable memory component compatible with a computer or other processing device.
- the ultrasonicator 10 may also be configured to produce hard copies of the data, such as a paper printout.
- the user interface 16 can also alert the operator, either through an audio or visual indicator such as a beeping sound, flashing light, or message within the display 16 a , if the sample approaches or exceeds any boundaries defining an acceptable range for a sample parameter or characteristic.
- This combined monitoring/alert feature can be advantageous in embodiments or operating modes that do not use feedback to adjust the treatment protocol during treatment.
- Treatment protocols and similar instructions for treating samples may be stored on a memory component 30 of the control system. In some cases it may be advantageous to store treatment protocols that are relatively specialized to specific uses, sample types, or objectives.
- the memory component may be fixed to the ultrasonicator 10 , such as a silicon chip or other hardware component, or may be configured to be readily removable and exchanged for other memory components, e.g., such that the operator can select a memory component comprising treatment protocols pertinent to the needs of the operator. For example, if the ultrasonicator 10 is reallocated to a different use, a different memory programmed with protocols or other programs appropriate may be used in place of the original memory component. Similarly, as improved protocols are developed, the operator can also acquire newer memories including these improved protocols.
- the interchangeable memory component can be a memory card that slides through a memory card slot 28 on the outer housing 18 .
- the memory card can be stored exterior to the outer housing 18 , similar to a flash drive.
- Other suitable interchangeable memory components include compact discs (CDs), compact discs with read-only memory (CD-ROMs), digital versatile discs (DVD), diskettes, flash drives, and memory chips.
- the ultrasonicator 10 can download treatments protocols from the internet, either onto an interchangeable memory component separable from the ultrasonicator 10 , directly to a memory component built into the ultrasonicator 10 , or to an ActiveX or other controller.
- FIG. 1B depicts a cross-sectional view of the interior 44 of the benchtop ultrasonicator 10 according to an embodiment of the invention.
- the interior of the ultrasonicator 10 can have a cavity 32 specially shaped to fit around and hold a suitable sample vessel 26 , such as a tube, that contains a sample 14 .
- the cavity 32 or any other suitable sample holder, can be substantially surrounded by a first fluid bath 34 that is contained within a sample tank 36 .
- the sample tank 36 can be suspended within a coupling medium, such as a second fluid bath 38 , through which an acoustic energy source 40 may transmit acoustic energy to the sample 14 .
- the second fluid bath 38 can be contained within an interior tank 42 of the ultrasonicator 10 .
- the sample tank 36 and acoustic energy source 40 are capable of moving, and their positions may each be controlled by the control system of the ultrasonicator 10 .
- At least a portion of the sample tank 36 can be made of a thin film material having low acoustic absorption and an acoustic impedance similar to the fluid within the second fluid bath 38 . This portion of the sample tank 36 may be arranged so that it is aligned with the acoustic energy source 40 .
- non-fluidic coupling means may be used.
- the acoustic energy can be transmitted through a viscous (semi-solid) layer 34 of, for example, silicone gel or rubber, or other material with a gel consistency or rubber consistency, which may optionally be sealed by an impervious membrane such as, for example, a plastic sheet or film, to form a laminate.
- a viscous (semi-solid) layer 34 of, for example, silicone gel or rubber, or other material with a gel consistency or rubber consistency, which may optionally be sealed by an impervious membrane such as, for example, a plastic sheet or film, to form a laminate.
- Exemplary suitable sound-transmitting media are listed in Table 1. This list, however, should not be viewed as comprehensive and exhaustive, and other acoustic coupling media with adequate sound transmission properties may be used instead.
- the sample vessel 26 may be pressed against the layer 34 for more efficient transfer of acoustic energy.
- the cover 12 may be configured to provide this pressure by having an interior portion of the cover 12 disposed in contact with the sample vessel 26 when the cover 12 is closed, such that the sample vessel is pressed against the layer 34 .
- the interior portion of the cover 12 may be coupled to a spring, bellows-like structure, or any other structure which can be compressed but also resists being compressed.
- Layer 34 may be free-floating on the fluid surface of fluid bath 38 or may be suitably supported in other ways, such as by making the membrane of the laminate of layer 34 in contact with fluid bath 38 more rigid, by a lattice frame (not shown) or the like.
- Table 1 lists the relative acoustic transmission of various materials relative to water (100%):
- FIG. 2 depicts an electronically controlled ultrasonic processing apparatus 100 that includes an ultrasound treatment system and associated electronics 200 , a positioning system 300 for the sample target 800 being treated, and a control system 400 which controls, generates, and modulates the ultrasound signal and controls the positioning system 300 in a predetermined manner that may or may not include a feedback mechanism.
- the source of acoustic energy 230 and the target 800 being treated are arranged in a fluid bath 600 , such as water, such that the source of acoustic energy 230 is oriented towards the target 800 .
- the target 800 may be positioned proximate the surface of the fluid bath 600 , above the source of acoustic energy 230 , all being contained within a sample processing vessel 500 .
- a temperature control unit 610 may be used to control the temperature of the fluid in the fluid bath 610 .
- An overpressure system 900 can control, for example, cavitation, by maintaining a positive pressure on the target 800 and may be adjusted, in a predetermined manner that may or may not include feedback processing, by a target pressure controller 910 that is connected to the control system 400 .
- Target 800 may be a sample, multiple samples, or other device, and may be contained in a variety of sample vessels.
- Sample vessels are sized and shaped as appropriate for the material to be treated, and can be any of a variety of shapes.
- a sample vessel can be an ampoule, vial, pouch, bag, or envelope.
- These and other sample vessels can be formed from such materials as polyethylene, polypropylene, poly(ethylene terephthalate) (PET), polystyrene, acetate, silicone, polyvinyl chloride (PVC), phenolic, glasses and other inorganic materials, metals such as aluminum and magnesium, and laminates such as polyethylene/aluminum and polyethylene/polyester.
- Certain configurations of a sample vessel can be made by vacuum forming, injection molding, casting, and other thermal and non-thermal processes.
- An ultrasound acoustic field 240 can be generated by the acoustic energy source 230 , for example, a focused piezoelectric ultrasound transducer, into the fluid bath 600 .
- the acoustic energy source 230 can be a 70 mm diameter spherically focused transducer having a focal length of 63 mm, which generates an ellipsoidal focal zone approximately 2 mm in diameter and 6 mm in axial length when operated at a frequency of about 1 MHz.
- the acoustic energy source 230 is positioned so that the focal zone is proximate the surface of the fluid bath 600 .
- the acoustic energy source 230 can be driven by an alternating voltage electrical signal generated electronically by the control system 400 .
- the positioning system 300 can include at least one motorized linear stage 330 that allows the target to be positioned according to a Cartesian coordinate system.
- the positioning system 300 may position and move the target 800 relative to the source 230 in three dimensions (x, y, z) and may optionally move either or both of the target 800 and the acoustic energy source 230 .
- the positioning system 300 can move target 800 during and as part of the treatment process and between processes, as when multiple samples or devices within the target 800 are to be processed in an automated or high-throughput format.
- the positioning system 300 may position or move the target 800 in a plane transverse to the focal axis of the acoustic energy source 230 (x and y axes).
- the positioning system 300 can position and move the target 800 along the focal axis of the acoustic energy source 230 and lift or lower the target 800 from or into the fluid bath 600 (z axis).
- the positioning system 300 can also position the acoustic energy source 230 and any or all of the sensors 700 in the fluid bath 600 along the focal axis of the acoustic energy source 230 , if the sensors 700 are not affixed in the water bath 600 , as well as lift, lower, or otherwise move the acoustic energy source 230 .
- the positioning system 300 also can be used to move other devices and equipment such as detection devices and heat exchange devices from or into the fluid bath 600 (z axis).
- the linear stages of the positioning mechanism 330 can be actuated by stepper motors (not shown), which are driven and controlled by electrical signals generated by the control system 400 , or other apparatus known to those skilled in the art.
- Sensors 700 can be used prior to, during, or after the acoustic treatment to analyze the samples and/or detect certain physical properties of the sample, for example, by measuring responses to electromagnetic stimulation, such as optical spectroscopy, energy dispersion, scattering absorption, and/or fluorescence emission.
- electromagnetic stimulation such as optical spectroscopy, energy dispersion, scattering absorption, and/or fluorescence emission.
- Other measurable variables can include electromagnetic properties, such as electrical conductivity, capacitance or inductivity, as well as other physical parameters, such as sample uniformity or pattern analysis.
- Exemplary sensors may include an additional ultrasonic acoustic transducer suitable to transmit and/or receive an acoustic probe interrogation beam which can be used to assess one or more characteristics, such as the fill level, temperature, cavitation, homogeneity (e.g., presence of absence of particulate matter in the solvent, and/or the size of such particles), volume, etc., of the sample located within the sample vessel.
- acoustic energy transducer 230 and the sensor transducer can be reversed in that the sensor transducer may operate to emit the acoustic processing beam while the transducer 230 performs sensing function.
- the system may include other types of sensors as well, such as an infrared (IR) temperature sensor to measure the sample temperature.
- IR infrared
- Interfaces such as an interface between air and water, cause reflection of an incident ultrasound field. While reflection should be minimized for transmitting acoustic energy to the sample, a signal emitted from the acoustic energy source 230 or from a separate sensor and reflected by an interface, such as the meniscus of the sample within the sample vessel, can be used to quantify the height and therefore also the volume of the sample.
- the sensor may be implemented as an acoustic transducer and emit a short burst of acoustic energy with a duration of 1 ms or less for interrogating the sample. Such short burst is also referred to as a “ping.” As mentioned above, the interrogation burst can be focused on the sample.
- the senor Due to reflection at the various interfaces encountered by the propagating interrogation sound wave, the sensor receives a return signal after a transit time proportional to the distance between the sensor and the respective interface. For example, it takes a sound wave approximately 10 ms to travel a distance of 1 cm, which is easily resolved by a detection system. The height location of the meniscus of the sample can then be determined from the arrival time difference between the sound wave reflected at the bottom of the sample, and the reflection at the liquid-air interface at the meniscus. The volume of the sample can be taken into consideration when applying acoustic energy for treatment of the sample.
- air bubbles and particulates can also block or reflect energy transmission through the sample volume.
- the same principle described above for determining the position of the meniscus can therefore also be used to evaluate the sample volume for the presence or absence of particulates, and/or the size and/or amount of such particles.
- the control system 400 can include a computer 410 , or other processor or microprocessor, and a user input/output device or devices 420 such as a keyboard, display, printer, etc.
- the control system is linked with the ultrasound treatment system 200 to drive the acoustic energy source 230 , with the positioning system 300 to drive the stepper motors described above, with one or more sensors 700 to detect and measure process parameters and/or sample characteristics, and with one or more controllers, such as the target pressure controller 910 , to alter conditions to which the target 800 is exposed.
- a fluid bath controller 610 could also be linked with the control system 400 to regulate temperature of the fluid bath 600 .
- the control system 400 can control and drive the positioning system 300 with the motion control board 310 , power amplifier device 320 , and motorized stage 330 , such that the target 800 can be positioned or moved during treatment relative to the source 230 to selectively expose the target 800 to acoustic energy.
- the control system 400 can specify a process to be performed upon a sample.
- the ultrasound treatment system 200 can include an arbitrary waveform generator 210 that drives an RF amplifier 220 , such that the acoustic energy source 230 receives an input.
- the output signal of the RF amplifier 220 may be conditioned by an impedance matching network and input to the acoustic energy source 230 .
- the control system 400 can generate a variety of useful alternating voltage waveforms to drive a acoustic energy source. For instance, a high power “treatment” interval consisting of about 5 to 1,000 sine waves, for example, at 1.1 MHz, may be followed by a low power “convection mixing” interval consisting of about 1,000 to 1,000,000 sine waves, for example, at the same frequency.
- “Dead times” or quiescent intervals of about 100 microseconds to 100 milliseconds, for example, may be programmed to occur between the treatment and convection mixing intervals.
- a combined waveform consisting of concatenated treatment intervals, convection mixing intervals, and dead time intervals may be defined by the operator or selected from a stored set of preprogrammed waveforms. The selected waveform may be repeated a specified number of times to achieve the desired treatment result.
- FIG. 3 depicts a control system 50 similar to control system 400 of FIG. 2 that includes a processor 54 , a user interface 56 , and a memory 52 .
- the control system 50 links to actuating systems 58 that implement processes specified by the control system 50 and to sensors 60 that may measure processing parameters and/or detect sample characteristics.
- Actuating systems 58 can include positioning systems, ultrasound treatment systems for driving a acoustic energy source, parameter controllers, and any other devices capable of implementing treatment processes, such as those described above in reference to FIG. 1 .
- Sensors 60 may monitor the impact and efficacy of a treatment process on a sample by detecting visual indicators, temperature, and/or cavitation. Sensors 60 may also detect initial characteristics of the sample like size, solubilization level, and type of sample vessel.
- the memory 52 can include preprogrammed waveforms, protocols, and functions from which the processor 54 can select when determining a treatment process.
- Protocols can include combined or alternating waveforms and any other instructions for any actuating systems 58 .
- the instructions are preferably predetermined to be advantageous for effecting a specific objective, such as enhancing a reaction, solubilizing the sample, or sterilization, for a specific sample type, which may be dependent on the sample contents, size, temperature, viscosity, level of solubility, vessel, or any other characteristics.
- Functions can configure a coordinated set of instructions for the actuating systems 58 or select a protocol based on input collected by the processor 54 .
- the input can be initial characteristics of the sample and/or process parameters that can be detected by sensors 60 or entered by an operator via the user interface 42 .
- a function can, given the volume and contents of a sample, determine the necessary waveform, duty cycle, and length of treatment to mix a sample without significant heating side effects.
- Other processing variables the function can determine include frequency, energy delivered, burst pattern, intensity, cycles per burst, pulse shape of the waveform, maximum energy level, etc.
- the processor 54 can select a process to implement based on a combination of user input from the user interface 42 and/or information from the sensors 60 .
- the user interface 42 allows an operator to design and specify a process to be performed upon a sample.
- the operator can directly control instructions to actuating systems 58 , select an option from the memory 52 , indicate characteristics of the sample and an objective, or some combination thereof.
- the user interface 42 can also communicate to the operator which treatment process options are available and data detected by the sensors 60 . Information from the sensors 60 can be used to configure a treatment process, to select a treatment process, or as feedback to a treatment process.
- measurable or discernible process attributes such as sample temperature, water bath temperature, intensity of acoustic cavitation, or visible evidence of mixing in the sample processing vessel, may be monitored by the control system 50 and employed in feedback loop to modify automatically during the treatment process any parameters controlled by actuating systems 58 , such as the treatment waveform or acoustic energy source position.
- the modification of the treatment waveform may be a proportional change to one or more of the waveform parameters or a substitution of one preprogrammed waveform for another.
- control system 50 may proportionally shorten the treatment interval and lengthen the convection mixing interval in response to the discrepancy between the actual and target sample temperatures. Or, alternatively, the control system 50 may substitute one predetermined waveform for another.
- the control system 50 may be programmed to terminate a process when one or more of the sensors 60 signal that the desired process result has been attained.
- initial characteristics of the sample may be used by the control system 50 to assess whether treatment is needed and/or to select a protocol or function optimized for those characteristics.
- Initial sample characteristics can include sample content, vessel, size, viscosity, temperature, pressure, and position relative to any of the actuating systems 58 .
- one of the sensors 60 may be adapted to recognize an identifying mark either affixed to the sample or scanned in separately by the operator.
- the control system 50 may associate the identifying mark with a corresponding waveform, parameter, protocol, or function, e.g., such that the corresponding aspect of the treatment is set automatically by the controller upon detection of the mark and/or executed automatically upon activation of the ultrasonicator 10 .
- the use of a preprogrammed protocol or function may eliminate the need for monitoring sensors during the treatment process.
- the control system 50 upon recognition of sufficient sample characteristics can implement a protocol optimized to render the desired effect on that sample while maintaining the sample within certain constraints such as temperature or pressure ranges, without relying on feedback from sensors 60 while the process is in progress.
- An embodiment without process monitoring capabilities may be advantageous in cases where a simplified acoustic treatment apparatus is desirable, such as a benchtop apparatus for processing a single sample.
- Acoustic treatment may be applied to many types of samples for a variety of purposes. Chemical and biological samples, as well as other types of samples, may be sterilized, mixed, or heated by acoustic treatment. Other applications are described in U.S. Pat. No. 6,719,449 entitled “Apparatus and Method for Controlling Sonic Treatment,” which is hereby incorporated by reference herein.
- One application in particular is the acoustic treatment of blood or blood-based samples. Treatments can be configured to sterilize a blood sample, to ensure homogeneity of a blood sample, to mix a blood sample with an agent such as an anti-coagulant or a test compound that tests for antibodies, and any other suitable applications that may arise.
- the ultrasonicator 10 described above in reference to FIG. 1 , can be adapted for blood treatment as well as for other applications, particularly applications involving small numbers or quantities of samples. In addition to clinical uses, the ultrasonicator 10 can be used in hospitals and doctor's offices to prepare or test blood or other samples.
- Acoustic treatment may be used to break up and/or mix components during food or beverage preparation, to prepare cosmetics, and to homogenize mixtures/suspensions/solutions that separate or otherwise become heterogeneous during storage, such as paint.
- acoustic treatment can break up food at the cellular level and/or form emulsions or suspensions. Possible uses include making milkshakes, mayonnaise, purees, foams, sauces, juices (e.g., from fresh produce), ice cream, and butter.
- Acoustic treatment may be used to prepare cosmetics, such as lipsticks, moisturizers, creams, emollients, liquid soaps, perfumes, astringents, and other suitable colloidal or liquid products, or agitate paint to uniformly mix colors and components.
- the ultrasonicator 10 can be adapted for these non-clinical applications and be useful in settings in which customization and/or portability of the device is desired.
- the ultrasonicator 10 can be a countertop appliance in consumer or commercial settings, allowing a user to freshly prepare a customized food product.
- customers in a retail setting can specify and mix colors, scents, and other ingredients for cosmetic products.
- the ultrasonicator 10 can allow a user to prepare paint for use.
- paint may be mixed at any desired location, for instance, by contractors or painters at a job site.
- the ultrasonicator 10 may also be used to create small samples of customized paint as an alternative to color swatches.
- FIGS. 4 and 5 depict illustrative processes for treating a pressurized sample with acoustic energy.
- FIGS. 4A and SA depict sample vessels for containing the sample and isolating it from other components of an acoustic energy apparatus.
- FIGS. 4B and 5B depict the sample vessels of FIGS. 4A and 5A , respectively, after samples have been deposited within the respective vessels.
- FIGS. 4C and SC depict the samples and sample vessels of FIGS. 4B and 5B , respectively, after they have been sealed closed and pressurized to pressurize the samples. Methods and apparatus for pressurizing samples within sample vessels are described in more detail below.
- FIGS. 4D and 5D depict acoustic energy sources applying acoustic energy to the pressurized samples and sealed sample vessels of FIGS. 4C and 5C , respectively.
- the acoustic energy dose required to cavitate the solution may be greater. This may increase the shear forces consequent to cavitation bubble collapse. This may also result in greater retention time of the sample in the focal zone of the applied acoustic field and/or reduced rate of sample escaping the focal zone. This in turn may effectively increase the collision frequency of the sample with the acoustic bubbles generated by the applied energy and/or increase their resultant shear forces upon bubble collapse.
- the pressurization of the sample during the ultrasonic treatment may effect a transient increase in the effective viscosity of the sample, and that the acoustic energy has a greater effect in this altered state.
- This increase in effective strength may result in the observation of finer particle formation, faster tissue homogenization, accelerated lysis of microbial organisms, or otherwise provide for increased precision or speed of processing using the acoustic energy treatment process.
- the sample may include a liquid or solution comprising a sample (e.g., tissue, cell, crystal, buffer, solvent, gel, gum, slurry, blend, single-walled carbon nanotubes, etc., or combination thereof).
- acoustic energy is applied to a solid sample, e.g., in a liquid or gaseous environment, to form particles of the solid material.
- the application of focused acoustic energy to a solid can cause it to break apart into increasingly smaller fragments than unfocused acoustic energy.
- acoustic energy can agitate sample pieces or particles, inducing collisions that promote further fracturing and/or fragmenting of the solids.
- acoustic energy is applied to a liquid sample, thereby inducing the formation of particles.
- acoustic energy can be applied to, a supersaturated solution, causing a solute to precipitate out of solution.
- acoustic energy can be applied to a biphasic liquid sample, inducing mixing or the phases and causing the precipitation of a solid.
- acoustic energy can be applied to a hot solution in conjunction with cooling, so that solids that precipitate during cooling are formed into particles of a desired size.
- the subject systems and methods can be applied to any procedure that results in the formation of a solid material in order to control the size and size distribution of the solid material that forms. Other procedures and desired results are described below.
- the entire acoustic circuit which in some embodiments includes a series of acoustic interfaces such as the transducer-couplant, couplant-vessel, vessel wall, vessel-inner sample, and sample-air/vapor headspace, may be pressurized, which may improve the efficiency of the treatment process.
- a pressurized fluid may transmit acoustic energy more efficiently than a non-pressurized fluid.
- FIG. 6 depicts an illustrative process for treating a pressurized sample with acoustic energy.
- FIG. 6 allows higher pressures to be obtained readily without requiring a special vessel, materials, or a custom design.
- FIG. 6A depicts an acoustic energy treatment system which includes an acoustic energy source 6002 coupled via a coupling medium 6004 to a sample vessel 6006 containing a sample 6008 , similar to the sample vessel 4010 depicted in FIG. 4B .
- the medium 6004 may be a fluid, such as water or buffer, or other compressible medium.
- FIG. 6B depicts the system of FIG. GA after it has been placed within an air-tight chamber 6010 and pressurized.
- both the sample 6008 and the medium 6004 coupling the acoustic energy source 6002 to the sample vessel 6006 are pressurized due to the elevated atmospheric pressure within the chamber 6010 .
- Methods and apparatus for pressurizing acoustic energy treatment systems are described in more detail below.
- FIG. 6C depicts the acoustic energy source applying acoustic energy 6012 via the pressurized medium 6004 to the pressurized sample 6008 .
- the pressurizing atmosphere may be compressed air, nitrogen, argon, helium, or any other suitable gases or combination thereof.
- gases may be preferred in certain applications, e.g., for their intrinsic physical properties such as inhibiting biological events, such as nitrogen, or because they may beneficially alter the cavitation threshold energy, such that an altered headspace over a fluidic or partially fluidic/solid sample more readily enables bubble formation and collapse.
- certain vessel designs may be used to apply pressure to a sample. These vessel designs may allow lab technician to apply pressure to a sample efficiently so that multiple samples can be processed with minimal time and effort.
- a sample vessel may have a sealing mechanism, for sealing the interior of the sample vessel from the external atmosphere, with which the lab technician, or any other user, may pressurize the sample.
- an acoustic energy apparatus processes a single sample, e.g., which is inserted into the device.
- a collection of samples may be inserted into the device, e.g., in a suitable rack, container, or other array for holding the collection of samples.
- a sealing cap is applied to an individual sample to simultaneously close and pressurize the sample.
- the sealing cap while engaging the vessel containing the sample, acts as a piston to pressurize the sample.
- FIG. 4C depicts an exemplary sealing cap 4002 for pressurizing a sample 4004 .
- the sealing cap 4002 has a bayonet portion 4006 encircled by a rim 4008 of approximately the same length as the bayonet portion 4006 .
- the size and shape of the rim 4008 is selected such that when the sealing cap 4002 initially engages the sample vessel 4010 , the rim 4008 seals off exposure of the sample 4004 , and the rest of the vessel interior 4012 , to the environment external to the vessel 4010 . As the sealing cap 4002 is further engaged with the vessel 4010 , such that the rim 4008 overlaps more of the walls of the sample vessel 4010 , the bayonet portion 4006 protrudes into the vessel interior 4012 to increase the pressure within the vessel 4010 , thereby pressurizing the sample 4004 .
- a sealing mechanism may include a displacement portion, such as the bayonet portion 4006 , that can protrude into the interior of the sample vessel to decrease the volume of the interior, thereby pressurizing the sample contained within the interior.
- FIG. 5 depicts an embodiment of a vessel 5000 used to apply pressure to sample or samples 5010 .
- the vessel chamber 5008 may be accessed through input 5004 .
- Input 5004 may be covered by a protective seal 5006 that is bonded or engaged with vessel chamber 5008 .
- Protective seal 5006 may be reversibly sealable so that sample or samples 5010 can be introduced into vessel chamber 5008 .
- Protective seal 5006 may be made from any combination of metal, glass, plastic, rubber, plastic film, or any other material suitable to form a bond with vessel chamber 5008 in order to provide a seal, e.g., to prevent sample from exiting the chamber during treatment.
- the seal may be air-tight, water-proof, and/or hermetic.
- Vessel chamber 5008 may be made from any combination of metal, glass, plastic, rubber, plastic film or any other suitable nonporous material that enables vessel chamber 5008 to provide a barrier between the sample or samples 5010 and an external environment.
- protective seal 5006 may comprise port 5002 .
- Port 5002 may be a reversibly sealable port, such as a one-way valve or a rubber septum, for accessing the vessel chamber 5008 , e.g., for supplying pressure to vessel chamber 5008 , and thus sample or samples 5010 .
- port 5002 may be shaped and sized to interface with a needle, such as a hypodermic needle, air injector, cannula, or similar feature.
- the needle may be used to add or remove materials, such as a sample, a liquid, or a gas, to or from the vessel chamber.
- the vessel chamber may be pressurized (e.g, with air, argon, nitrogen, or another suitable gas) prior to the introduction of the sample or sample medium via a needle.
- a needle may be used to inject a liquid or gas into vessel chamber 5008 after introduction of the sample in order to increase the pressure within vessel chamber 5008 .
- the liquid or gas so introduced may be an inert gas, compressed air, a solvent for the sample, or a suitable treatment medium for the sample.
- the needle may be coupled to a mechanical or manual air pump to increase the pressure of the environment within vessel chamber 5008 .
- the needle may be attached to a bulb.
- the bulb may be made out of a malleable and durable material such as rubber, plastic, or any other suitable material that is able to deform nondestructively and preferably reversibly when mechanically squeezed.
- the bulb may be shaped and sized so that the volume of the bulb is greater than the volume of the vessel chamber 5008 .
- the bulb may be squeezed or otherwise deformed to inject a liquid or gas into vessel chamber 5008 in order to increase the pressure within vessel chamber 5008 .
- vessel 5000 permits sample or samples 5010 to be exposed to higher pressures in order to facilitate processing of the sample or samples.
- FIG. 7 depicts an embodiment of an automatic pressurizing device 7002 to increase the pressure of the environment within a sealed vessel chamber, such as the sealed vessels of FIG. 5 .
- the device includes a needle 7006 adapted to reversibly penetrate a seal, such as a rubber septum, a gas source 7008 , (e.g., a canister of compressed air, nitrogen, argon, or other suitable gas or mixture thereof), and optionally a pressure sensor 7004 .
- Pressure sensor 7004 measures the pressure of the environment at the end of the needle 7006 , and may be mechanical or digital.
- Digital pressure sensors may include piezoresistive semiconductors, microelectromechanical system chips, variable capacitors, or other hardware to suitably detect the pressure of an environment.
- the automatic pressurizing device 7002 may be configured to automatically pressurize the chamber in an automated fashion when the needle 7006 is inserted into a sample until a desired level of pressure is reached within the sample chamber.
- the automatic pressurizing device 7002 may be triggered by the force exerted on the needle when it is pushed through a septum, or it may be triggered by force applied to a trigger external to the needle 7006 .
- the trigger may comprise, for example, a guard 7010 in the vicinity of the needle that contacts the septum as the needle penetrates the septum, or a manual trigger such as a button or lever operated by the user (not shown).
- the automatic pressurizing device 7002 may add gas to the chamber until a predetermined pressure is reached, e.g., the pressure of the gas source 7008 , or a pressure set by the user or the manufacturer of the device, e.g., via an interface (not shown).
- a predetermined pressure e.g., the pressure of the gas source 7008 , or a pressure set by the user or the manufacturer of the device, e.g., via an interface (not shown).
- the pressure sensor 7004 may communicate with a controller that can operate to open or close a pathway between the gas source 7008 and the needle 7006 so that the correct amount of pressure is reached in a vessel chamber. This communication may occur through electrical means, such as a wire, RFID, or wireless communication, or any other suitable means.
- a sample vessel may be sealed with a pierceable septum.
- the sample may be contained within a 13 mm ⁇ 65 mm round bottom borosilicate glass culture tube (Chromocol, UK) with a screw cap end that is sealed with a Bakelite cap having a rubber septum center.
- a needle such as a 22-gauge, 1.5-inch hypodermic needle, can be inserted through the septum to apply elevated pressure through the needle. The pressure equilibrates through the needle bore, pressurizing the interior of the tube and the sample.
- High-intensity focused ultrasound (“HIFU”) acoustic energy (as used with the Covaris, Woburn, Mass., USA S-series instruments) can then be applied to process the sample in the tube.
- the pressure may be allowed to equilibrate to atmospheric pressure, and then the sample may be removed from the tube, e.g., by inserting the needle further into the tube to collect the fluidic sample in a manual manner.
- the pressure in the tube may be used to eject the sample, e.g., through a cannula inserted through the septum into the sample. All or part of the above-described process, including sample preparation, sealing, pressurization, treatment, depressurization, and sample removal, may be readily automated.
- the needle though inserted into the sample chamber, is not in the focused acoustic energy field.
- the needle may be located in the acoustic focal zone, e.g., as a nucleation site for cavitation events.
- a single sample or a batch of single samples are inserted into an apparatus and pressurized prior to the application of acoustic energy.
- a microtitre plate with 96 350-microliter sample wells may be loaded with 100 microliters per well.
- the open plate may be inserted into an apparatus which allows the atmosphere at the fluid/air interface of the samples to be elevated prior to an acoustic dose.
- the plate may be sealed prior to treatment with a lid that either pressurizes each well (e.g., via a piston-type approach, as discussed above) or allows the sealed compartment to be pressurized (e.g., through a septum or one-way valve, as discussed above).
- a sample vessel may have one or more flexible or elastic walls to allow the volume of the interior of the sample vessel to decrease, thereby increasing the pressure.
- One of the walls, or portion of a wall, of the sample vessel may be sufficiently pliable to allow increased pressure external to the pliable wall to be transmitted to the contained sample.
- a plastic bag, a balloon, a test tube having a slidably engaged piston plunger, or other sample vessel having a deformable structure may shrink in volume when placed in an elevated pressure atmosphere, thereby pressurizing the sample, even though the sample remains sealed from the external environment.
- an external force may be applied to the sample vessel to shrink the volume of the vessel interior. The application of the external force may be automated or may comprise a user of an acoustic treatment apparatus physically manipulating the sample vessel to deform its structure.
- FIG. 8 depicts another embodiment of a vessel 8000 used to apply pressure to sample or samples 8010 .
- the vessel chamber 8008 may be accessed through input 8002 .
- Vessel chamber 8008 may be made from any combination of metal, glass, plastic, rubber, plastic film or any other suitable nonporous material that enables vessel chamber 8008 to provide a barrier between the sample or samples 8010 and an external environment.
- Input 8002 may be shaped and sized to interface with plunger 8004 .
- Plunger 8004 may comprise a stopper 8006 coupled to a stem 8007 .
- the length of stem 8007 of plunger 8004 may be equal to or greater in length than the length of vessel chamber 8008 , but is typically sufficiently long to facilitate movement of the stopper 8006 through a range of positions within the vessel chamber.
- Stopper 8006 of plunger 8004 may be shaped and sized to form a seal with input 8002 .
- Stopper 8006 of plunger 8004 may be made out of rubber, plastic, or any other suitable material to form a seal with input 8002 .
- the seal is preferably airtight.
- Stem 8007 of plunger 8004 may be made out of glass, plastic, or any other suitable material that allows a user or an automated device to employ stem 8007 of plunger 8004 and deliver a downward force to reduce the volume of the vessel chamber 8008 , thereby increasing the pressure in the chamber.
- Stem 8007 of plunger 8004 may also be shaped and sized so that it may be employed to apply an upward force to remove stopper 8006 from the vessel chamber 8008 so that the pressure within vessel chamber 8008 may be reduced and/or the vessel chamber can be accessed.
- vessel 8000 may be employed to expose sample or samples 8010 to higher pressures in order to facilitate processing of the sample or samples.
- FIG. 9 depicts another embodiment of a vessel 9000 used to apply pressure to sample or samples 9010 .
- Sample or samples 9010 may be placed inside vessel chamber 9008 through input port 9002 .
- Vessel chamber 9008 may be made out of a substantially malleable yet durable material such that vessel chamber 9008 deforms nondestructively when physically manipulated and provides a barrier between the sample or samples 9010 and an external environment. Suitable materials include rubber, metal foil (e.g., aluminum), plastic, or any combination thereof.
- Vessel 9000 also includes bottom 9006 . Bottom 9006 may be shaped and sized to fit into a sample holding device such as a 96-well plate, or any suitable sample holding device.
- input port 9002 may be shaped and sized to be clamped by clip 9012 .
- Clip 9012 may be made out of plastic, rubber, or any material suitable to clamp input port 9002 .
- Clip 9012 may be shaped and sized to slide up and down the body of the vessel chamber 9008 and hold a fixed position after movement.
- Clip 9012 may be removable (e.g., to access vessel chamber 9008 through input port 9002 ), and preferably seals vessel chamber 9008 , e.g., for treatment, such as with an airtight seal.
- input port 9002 may be located on the side of the vessel 9000 , such that the clip 9012 slides up and down the body and over the port 9002 , thus reversibly sealing the vessel chamber 9008 .
- manipulating clip 9012 parts of the vessel body 9008 may deform nondestructively.
- manipulating clip 9012 may reduce the volume of vessel chamber 9008 .
- the vessel chamber 9008 may be pressurized.
- vessel 9000 may be employed to expose sample or samples 9010 to higher pressures in order to facilitate processing of the sample or samples.
- focused acoustic energy is applied to a flowing fluid stream exposed to elevated pressure prior to and/or during acoustic energy treatment.
- This embodiment may form part of a flow-through or intermittent flow system that may be employed in the production of fine chemicals, food products, pharmaceuticals, cosmetics, and in other manufacturing settings.
- this system may include a cell with a quartz window for acoustic energy transmission.
- the flowing fluid stream passes through a constriction which elevates the pressure on the fluid in the region preceding the constriction.
- the entire transducer may be contained within the flowing stream of a sample to be processed that is intermittently pressurized.
- a focused acoustic energy apparatus may synchronize the flow with the acoustic dose to achieve the desired result (e.g., crystal dissolution, sonocrystallization, and the like). This continuous flow process may also be automated.
- the size of the starting lambda DNA was 48,502 bp. After treatment at 14.7 psi, the majority of the DNA fragments were in the 100 to 650 bp size range. After treatment at 29 psi, the majority of the DNA fragments were in the 100 to 500 bp size range; and at pressures of 44 and 57 psi, the majority of the DNA fragments were in the 100 to 375 bp range, as summarized in Table 1 below.
- the DNA shearing described in example one may also be controlled by the variation of the pressure level, e.g., 1, 2, and 3 atmospheres (“atms”) and beyond.
- the pressure level e.g. 1, 2, and 3 atmospheres (“atms”) and beyond.
- HAP hydroxyapatite
- a suspension of ceramic hydroxyapatite particles was prepared by placing 3.1 mg of ceramic hydroxyapatite particles (20 Am from Bio-Rad, Hercules, Calif.) in a 13 ⁇ 65 mm glass round bottom screw cap tube and adding 2.0 ml of 50 mM trisodium citrate. The tube was capped and immediately processed in a Covaris S2 instrument with the following treatment parameters: power track mode, water bath temperature 8 degree C., 10% duty cycle, 10 intensity, 200 cycles per burst, and 30 seconds of treatment. The contents of the glass tube were then transferred to a cuvette and left undisturbed for 300 seconds to allow any large particles present to settle out. The cuvette was then placed in a spectrophotometer and the absorbance at 600 nm measured. The absorbance is due to light scatterings by the small particles that remain in suspension and thereby provides a measure of the amount of small particles generated by the acoustic treatment.
- the cap of the 13 ⁇ 65 mm tube was fitted with a tubing connection and a section of Tygon tubing that connected the glass tube to a pressure regulator that was, in turn, connected to a compressed air supply.
- Control experiments run at atmospheric pressure (approximately 15 psi) had an absorbance reading of 0.699 after 30 second of the above treatment.
- Experiments at elevated pressure were run at approximately 45 psi with compressed air and had an absorbance reading of 1.442 after 30 seconds of acoustic treatment. Thus the rate of fragmentation during the first 30 seconds of acoustic treatment was doubled when the pressure was increased to 45 psi.
- Yeast spores are more readily disrupted with the elevated pre-pressurization prior to application of focused acoustic energy. This pressurization may render the spores more susceptible to the effects of HIFU. Treating yeast while at elevated pressures may increase the lysis of yeast cells.
- Yeast cells from a frozen stock were suspended in 1.5 ml of 33 mM potassium phosphate pH 7.5 buffer in a 13 ⁇ 65 mm glass round bottom screw cap tube. 25 ⁇ l of a lyticase (Sigma, St. Louis, Mo.) stock (500 units/ml in cold distilled H20 made fresh daily) was added to the tube. The tube was capped and processed with a Covaris S2 instrument. The acoustic treatments were run in the power tracking mode with a water bath temperature of 26+/ ⁇ 1 degree C. The control sample was run at atmospheric pressure with brief low power acoustic mixing to keep the yeast cells in suspension.
- a lyticase Sigma, St. Louis, Mo.
- the low power treatment parameters were as follows: 1% duty cycle, 3 intensity, 200 cycles per burst, for 10 seconds; then 1% duty cycle, 0.1 intensity, 50 cycles per burst, for 50 seconds. These steps were repeated to generate the selected total treatment time.
- the parameters for high power treatment were: 20% duty cycle, 10 intensity, 200 cycles per burst, 30 seconds; then 1% duty cycle, 0.1 intensity, 50 cycles per burst 60 seconds; and again 20% duty cycle, 10 intensity, 200 cycles per burst, 30 seconds.
- the pressure in the tube was increased to 45 psi as described in Example 3 above. 60 ⁇ l aliquots were removed from the glass tubes at selected time intervals and transferred to a 0.65 ml microcentrifuge tube.
- the tube was centrifuged at 10,000 rpm for 1.5 minutes to pellet the cells; 50 ⁇ l of the supernatant was assayed for soluble protein using the Bradford dye binding assay (the absorbance at 595 nm is proportional to the protein concentration).
- FIG. 10 depicts a graph showing absorbance of yeast samples after acoustic treatment at various durations, pressures, and acoustic intensities.
- the line labeled “Aco. Mix” represents results from using an acoustic mix that was low power and sub-cavitation energy to gently resuspend yeast during incubation.
- the line labeled “15 psi” represents results from using a high power focused acoustic field at atmospheric pressure.
- the line labeled “45 psi” represents results from using a high power focused acoustic field at elevated pressure.
- the control had a protein assay absorbance of 0.049; the high power acoustic treatment at atmospheric pressure (15 psi) had an absorbance of 0.174; and the high power acoustic treatment at 45 psi had an absorbance of 0.415.
- High power acoustic treatment at atmospheric pressure resulted in a 3.5-fold increase in the protein assay absorbance over the control.
- High power acoustic treatment at elevated pressure, namely 45 psi resulted in an 8-fold increase in the protein assay absorbance over the control and a 2-fold increase over the high power treatment at atmospheric pressure, and appeared to reach end-point in 12 minutes.
- the first-named reference above discloses apparatuses and methods for exposing a sample to acoustic energy and for selectively controlling acoustic energy and/or the location of the sample relative to acoustic energy that may be used in conjunction with the invention disclosed herein.
- the first reference discloses various acoustic energy sources, electronics and waveforms, positioning systems, sensors, control systems, sample vessels, materials for treatments, and applications of acoustic treatment.
- the second-named reference above discloses systems, methods, and devices relating to processing a sample that may be used in conjunction with the invention disclosed herein.
- the second reference discloses various sample vessels and systems and methods for collecting, stabilizing, fragmenting and/or analyzing samples.
- the third-named reference above discloses systems, methods, and devices relating to coupling acoustic energy to a sample vessel to lower acoustic energy requirements to obtain desired process results, such as mixing.
Abstract
This invention relates to systems and methods for applying acoustic energy to a sample. According to one aspect of the invention, a system comprises a housing, a chamber for receiving the sample, an acoustic energy source for providing a focused acoustic field to the sample according to a treatment protocol, a processor for determining the treatment protocol, a sensor for detecting information about the sample, and a user interface for communicating with a user.
Description
- This application is a continuation of U.S. patent application Ser. No. 11/888,708 filed Aug. 1, 2007 entitled “Methods and Apparatus for Treating Samples with Acoustic Energy,” which claims the benefit of priority from U.S. Provisional Patent Application No. 60/834,979 filed Aug. 1, 2006 entitled “Methods and Apparatus for Treating Samples with Acoustic Energy” and U.S. Provisional Patent Application No. 60/923,335 filed Apr. 13, 2007 entitled “Methods and Apparatus for Focused Ultrasonic Sample Processing under High Pressure.” The disclosures of each of the foregoing applications is incorporated herein by reference in their entirety.
- The invention generally relates to the field of controlled acoustic energy-emitting devices for treating biological and/or chemical material, and more particularly to performing such treatment in a laboratory or benchtop setting.
- Ultrasonics have been utilized for many years in a variety of diagnostic, therapeutic, and research purposes. Some uses of ultrasonic or acoustic energy in materials processing include breaking up and/or mixing of fluid suspensions of materials. Additional uses are in solubilizing or otherwise ensuring that all or substantially all of the constituents of a sample are in solution and/or in suspension. Regardless of the particular use, sample materials are typically contained in a plastic or glass enclosure, such as vials, tubes, culture plates/well, or micro-titer plates, with an acoustic transducer coupled to the sample by way of a coupling medium, such as water. Typically, systems in which acoustic energy is precisely controlled and transferred to a sample in a vessel are relatively low power. Examples of low power systems include high-frequency, low-intensity focused acoustic dispensing systems, which transfer droplets of sample from a fluid-air interface through an air gap to a receiving vessel, and high-frequency focused interrogation systems commonly used in non-destructive testing of materials. Alternatively, acoustic transducers can be directly immersed in the material to be treated. This type of system, in which an acoustic transducer directly contacts the sample, is capable of relatively high power; however, it is typically of lower frequency. A distinct disadvantage of lower frequency systems is the lack of control inherent with long wavelength acoustics. For example, the low-frequency probe-type sonicator typically used in biological and chemical laboratories is operated at approximately 15 KHz, which results in wavelengths in aqueous media measuring several centimeters. Other systems can implement both high-power and high-control processing of diverse samples. However, there exists a need for a system with both high-power and high-control which is easy to use on a routine basis with minimal a priori sample preparation, process optimization, or operator training.
- The foregoing arrangements have been used for a number of applications, including large-scale batch processing, yet there is still a need for acoustic systems and methods that are more flexible, convenient, and effective, in particular for on-demand uses, such as for automated processing of small quantities of samples, for example, in laboratory or benchtop settings.
- The invention provides methods and systems for selectively exposing a sample or samples to acoustic energy in a benchtop or laboratory setting for the purpose of, for example, heating, fluidizing, mixing, stirring, disrupting, comminuting, sterilizing, or solubilizing the sample, or for enhancing a reaction in the sample. The foregoing applications are merely illustrative, and one skilled in the art will recognize other uses for the application of focused acoustic energy. Altering the sample in a controlled manner, especially biological and chemical samples, allows manipulation of the sample while preserving the viability, chemical and/or biological activity of the material. Samples may comprise one or more constituents such as, for example, solvents, reagents, nucleic acids, proteins, small organic or inorganic molecules, chemical compounds, or pharmaceutical or biopharmaceutical agents. Non-clinical samples may also advantageously be treated by acoustic energy. A sample to be processed with acoustic energy may be physically isolated in a vessel from the surrounding environment and an acoustic energy source (e.g., transducer) which applies acoustic energy to the sample. The acoustic energy may be applied to the sample through a coupling medium such as water.
- The term “acoustic energy” used herein refers to acoustic energy, acoustic waves, acoustic pulses, including forms of ultrasonic energy and/or shock waves. As used herein, sonic energy/acoustic energy refers to the focused, high frequency (e.g., typically 100 kHz-100 MHz; greater than 500 kHz; greater than or approximately equal to 1 MHz; etc), short wavelength (e.g., approximately 1-1.5 mm), acoustic energy. As used herein, focal zone or focal point means an area where sonic energy converges and/or impinges on a target, although that area of convergence is not necessarily a single focused point. According to one aspect, the present invention provides an acoustic energy source that provides a focused acoustic field. The acoustic energy source can be a focused transducer having a focal length, which generates an ellipsoidal focal zone. The focused transducer may be spherical, ellipsoidal, cylindrical, or any other suitable shape. The acoustic focal length of the focused transducer may be any suitable length, e.g., from 0.1-65 mm or more in diameter. The focal zone resulting from the focused transducer may be between 0.1 millimeter and 2 centimeters in diameter, e.g., between 0.1 mm and 100 mm, or between 0.1 nun and 10 mm, and the axial length of the focal zone may be between 0.1 millimeter and 6 centimeters, for example, depending on the size of the sample vessel.
- In one aspect, the present invention provides a benchtop apparatus that can treat a sample effectively with little input from a user. In certain embodiments, the apparatus may also offer the user varying degrees of control over the treatment applied to the sample. In certain embodiments, an apparatus of the invention may feature one or more components such as a user interface for communicating with the user or an easily accessed chamber for holding the sample.
- In certain embodiments, an apparatus of the invention may include an interchangeable memory component for storing treatment protocols. Interchangeable memory components can include memory cards, flash drives, CDs, DVDs, CD-ROMs, diskettes, chips, and any other suitable memory storage device. Treatment protocols may be preprogrammed, adjust to inputs from the user, adjust to measured changes in the sample during the treatment process, be based on initial conditions or characteristics of the sample, and/or be configured manually by the user. Operation of the apparatus can be at least partially automated. Steps that may be automated include selecting treatment parameters, selecting a treatment protocol, initiating acoustic treatment, and monitoring of sample parameters during treatment.
- For example, the acoustic energy delivered to the sample may be adjusted by the controller according to the volume of the sample, the sample temperature, and/or based on the type or concentration of particulate matter in the sample, for the purpose of, for example, comminuting the particles. The sensors may include temperature sensors, pressure sensors, optical sensors, such as infrared sensor, microscopes and/or video cameras, lasers, acoustic sensors such as electromagnetic or piezoelectric sensors, or a combination of such sensors. The sensors may be arranged coaxially or at an angle to each other.
- The sensors may be employed for measuring a physical characteristic of one or more samples before, during and/or following acoustic treatment of the samples. The results of the measured characteristic can be stored for use in subsequent processing steps or to compile a treatment history for the sample(s). For example, samples may be selected for further processing or interchanged for other samples based on their previously measured characteristics, or samples may be grouped and/or classified based on treatment history. Similarly, a characteristic measured post-treatment can be assessed by itself or can be compared to the characteristic measured pre-treatment and used to determine whether a desired condition of the sample has been reached and/or to assign a subsequent treatment or processing step for the sample.
- The samples may be coupled to the acoustic energy source by a liquid, semi-solid or solid medium. For example, the acoustic transducer may be placed in a tray surrounded by a fluid with a high transmissivity for the acoustic energy, and the semi-solid or solid layer may be placed between the fluid and the sample to prevent direct contact between the sample and the fluid. The semi-solid or solid layer may be made of silicone gel, elastomeric polyurethane, thermoplastic elastomer and the like, and may also have an additional cover layer to further protect the sample from contamination.
- According to the systems and methods disclosed herein, pressure may be applied to the sample or to the medium transmitting the acoustic energy, for example, by pressurizing the fluid, to improve acoustic coupling between the acoustic energy source and the sample. In another embodiment, the isolated sample inside a vessel may be pressurized relative to standard atmospheric pressure (e.g., to 2, 3, 4, or more •atmospheres of pressure) to improve sample processing. When focused acoustic energy is subsequently applied to the sample, the desired result may be obtained in a shorter time period and/or, in some applications, may also result in improved sample processing and output quality (e.g., a narrower size distribution in a sheared DNA strand population).
- Features and advantages of the invention will be apparent upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which like reference characters refer to like parts and in which:
-
FIG. 1A depicts an exterior view of a benchtop apparatus for processing a sample according to an embodiment of the invention; -
FIG. 1B depicts a cross-sectional view of the interior of a benchtop apparatus for processing a single sample according to an embodiment of the invention; -
FIG. 2 is a schematic illustration of one embodiment of the apparatus according to an embodiment of the invention; -
FIG. 3 is a schematic illustration of one embodiment of a control system according to an embodiment of the invention; -
FIGS. 4A-4D depict an illustrative process for treating a pressurized sample with acoustic energy according to an embodiment of the invention; -
FIGS. 5A-5D depict an illustrative process for treating a pressurized sample with acoustic energy according to an embodiment of the invention; -
FIGS. 6A-6C depict an illustrative process for treating a pressurized sample with acoustic energy according to an embodiment of the invention; -
FIG. 7 depicts an illustrative pressurizing device according to an embodiment of the invention; -
FIG. 8 depicts an illustrative vessel according to an embodiment of the invention; -
FIG. 9 depicts an illustrative vessel according to an embodiment of the invention; and -
FIG. 10 depicts a graph of the absorbance of yeast samples after treatment at various durations, pressures, and acoustic intensities. -
FIGS. 1A and 1B depict, respectively, an exterior view and an interior cross-sectional view of abenchtop ultrasonicator 10 for processing asample 14 according to an embodiment of the invention. Theultrasonicator 10 is adapted for use by a single operator, and is generally sized to fit on and be supported by a table or bench in a laboratory setting. Theultrasonicator 10 can have auser interface 16 disposed on anouter housing 18, which can include acover 12, or other access mechanism, for accessing the interior of theultrasonicator 10. In particular, the access mechanism may allow access to a chamber within theouter housing 18. - The operator can access the
ultrasonicator 10 by opening thecover 12. Thecover 12 may open by detaching from theouter housing 18, by tilting on a hinge that attaches one side of thecover 12 to theouter housing 18, by sliding laterally along grooves that engage thecover 12 on theouter housing 18, by rotating in a lateral direction along a joint that attaches a corner of thecover 12 to theouter housing 18, or any other suitable mechanism. The mechanism may include one or more buttons, tabs, handles, latches, or catches that may be depressed, pulled, toggled, engaged/disengaged, or rotated to open and/or close thecover 12. Alternatively, theultrasonicator 10 may be remotely controlled. For example, a USB or RS232 connector may link theultrasonicator 10 to a robotic system that may, for example, use ActiveX control or any other suitable control protocol. In embodiments where thecover 12 slides laterally along grooves on theouter housing 18, thecover 12 may, for example, be disposed on the outer surface of the housing, or may be disposed in a recess within thehousing 18. The mechanisms may be at least partially controlled electronically, such that the operator pushes a button on theuser interface 16 or elsewhere on theouter housing 18 to open and/or close thecover 12. Althoughultrasonicator 10 is depicted with thecover 12 being disposed on its top surface, one of skill in the art will recognize that other embodiments may additionally or instead have a door or cover 12 on a side of theouter housing 18, a drawer that slides laterally from theouter housing 18, or any other suitable mechanism for accessing the interior of theultrasonicator 10. In certain embodiments, theultrasonicator 10 may include a latch or other means for securing thecover 12 in a closed position during operation of theultrasonicator 10. In certain embodiments, theultrasonicator 10 may include a safety mechanism such that the device will not operate when thecover 12 is in an open position. In certain embodiments, thecover 12 in a closed position forms an airtight seal with theouter housing 18, to permit pressurization of the treatment chamber relative to the surrounding atmosphere. - The
cover 12 may be made of the same material as theouter housing 18, which can be made of any suitable material, such as plastic, glass, metal, etc. The interior of the cover may be lined with soundproofing material capable of dampening acoustic energy so as to reduce danger, disruption, or annoyance to the operator, e.g., to allow the device to operate quietly or silently in the perception of the user. The soundproofing material may be configured to absorb any acoustic energy that reaches it, or to reflect the acoustic energy back towards thesample 14. Theouter housing 18 can be between about 5 centimeters and about 30 centimeters in width, height, or length. - In certain embodiments, a
ultrasonicator 10 may include asensor 20 on theouter housing 18 that triggers thecover 12 to open. Thesensor 20 may be placed on theupper portion 22 of theouter housing 18, or any other suitable location, preferably selected to avoid accidental activation. Thesensor 20 may include a motion detector configured to detect motion within a predetermined range, such as about 5 inches, so that the operator may move his/her hand or asample 14 over thesensor 20 to trigger thecover 12, but motion further from theultrasonicator 10 would not trigger thecover 12. - In certain embodiments, the
sensor 20 may be configured to detect information about thesample 14. For example, thesample 14 could be labeled with a radio frequency identification (RFID) tag, text, a barcode, a symbol, or any other type of identifying mark, whichsensor 20 could recognize using an RFID interrogator, optical recognition, acoustic recognition, or any other suitable means. In certain embodiments, thesample 14 could be marked using a special ink, a reflective material, or other distinguishing features that could be recognized usingsensor 20. - Upon accessing the
ultrasonicator 10, the operator may place thesample 14 within asample holder 24 adapted to hold asample vessel 26 containing thesample 14.Suitable sample vessels 26 include tubes, vials, aerosol vials, flasks, jars, bottles, wells, arrays, blister packs, ampoules, pouches, bags, envelopes, and other containers that are manipulable by the operator and capable of containing a sample under sonication conditions. In certain embodiments, thesample holder 24 can be a concavity or depression having a shape similar to an outer surface of thesample vessel 26, such that thesample vessel 26 can nest within the concavity or depression. Thesample holder 24 can include a clamp, clip, or any other suitable fastener capable of holding thesample vessel 26 in place, e.g., around the neck of a flask or bottle, or around the body of a jar or tube. Thesample holder 24 may also be configured to detect information about thesample 14. For instance, an adjustable clamp can encircle a test tube to both hold the test tube in place and measure the circumference of the test tube. A concavity or depression can be equipped with a scale to weigh thesample vessel 26 andsample 14. Theultrasonicator 10 may have other sensors or interrogation systems capable of detecting characteristics of thesample 14. For instance, theultrasonicator 10 may detect an identifying mark, the location of thesample vessel 26, the level of fluid in thesample vessel 26, or any other initial characteristics of thesample 14. Other suitable characteristics and sensors are discussed in more detail below in reference toFIG. 2 . Theultrasonicator 10 may also include a safety mechanism for determining that thesample 14 has been appropriately and securely positioned in thesample holder 24, such that theultrasonicator 10 will not operate unless thesample 14 is appropriately and securely positioned. - In certain embodiments, the user may close the
cover 12 manually. Alternatively, theultrasonicator 10 may automatically close thecover 12, e.g., when the user activates theultrasonicator 10 and/or when theultrasonicator 10 determines that the sample is ready for sonication. Theultrasonicator 10 may also automatically devise and then execute a treatment protocol for thesample 14, or may prompt the operator to select or devise a treatment protocol using theuser interface 16. Theultrasonicator 10 may also signal when the treatment protocol is finished, for example, by emitting an audio signal, turning an indicator light on or off, flashing or displaying a message on theuser interface 16, or re-opening thecover 12. - The user, or operator, can use the
user interface 16 to communicate with a control system of theultrasonicator 10 which controls the operation of theultrasonicator 10. Generally, theuser interface 16 can query the user for input that may be communicated to a processor of the control system. Theuser interface 16 can include adisplay 16 a to communicate information such as which treatment process options are available, the value of a particular setting, or data detected by any sensors theultrasonicator 10 may have. Theuser interface 16 may also have buttons, dials, touchpads, knobs, sliders, or any other suitable control interfaces 16 b with which an operator may indicate preferences, instructions, or parameters to theultrasonicator 10. In one possible mode of operation of theultrasonicator 10, the control system automatically devises and executes a treatment protocol upon detecting the presence of asample 14 properly disposed within theultrasonicator 10 and/or other sample characteristics, including any identifying marks. In another possible mode of operation, theuser interface 16 prompts the operator to input information that the control system can use to select a treatment protocol. In one embodiment, the operator can manually configure a treatment protocol, for instance by selecting which waveform(s) to use, the duty cycle, the total energy, the relative positioning of thesample 14 to a acoustic energy source, and/or any other treatment parameters. In another embodiment, the operator can select a treatment protocol from a set of preprogrammed treatment protocols. The preprogrammed treatment protocols can be configured to each achieve a different objective or desired result, such as sterilization, mixing, reaction enhancement, and any other application of acoustic treatment. Each preprogrammed treatment protocol can also be configured to correspond to a particular sample, where the control system uses the characteristics of a particular sample either detected by sensors of theultrasonicator 10 or from information entered by the operator via theuser interface 16. In yet another embodiment, the operator can input information about the sample, such as the sample size, sample vessel, and desired objective or result, and then the control system automatically selects and executes a treatment protocol based on the information from the operator. The operator may also input acceptable ranges for any measured sample characteristics or parameters, such as temperature and pressure, which can help guide the control system's selection of a treatment protocol. In yet another embodiment, the operator can adjust the treatment protocol during the treatment process, for instance by lowering or raising the duty cycle, modifying the waveform, and/or switching to a different treatment protocol. The operator may also designate whether or not the treatment protocol should feedback information about the sample from sensors during the treatment process to adjust the treatment protocol. The control system can make feedback adjustments according to instructions from a preprogrammed treatment protocol and/or input from the operator. Further information about the control system is described below in reference toFIG. 3 . - The
user interface 16 can have an input mechanism that when activated initiates application of a focused acoustic field provided by the acoustic energy source to thesample 14. For example, theuser interface 16 can have a pulse button that initiates sonication when the pulse button is pressed and stops sonication, for example, when the pulse button is released or pressed a second time. The parameters of the acoustic treatment can be preset by either the control system or the operator to a default treatment process, or may be selected by the operator at each use. Theuser interface 16 can have multiple pulse buttons, each corresponding to a different application, sample size, and/or treatment protocol. - In addition to allowing the operator to indicate his/her selections to the control system of the
ultrasonicator 10, theuser interface 16 can Impart information to the operator, such as which treatment protocols and/or operating modes (e.g., feedback mode, fully automatic mode, etc.) are available to the operator. Theuser interface 16 can also display information measured, detected, or recognized by any sensors of theultrasonicator 10, such as a sample ID from an identifying mark, sample temperature, or sample size. Information from sensors can be continuously displayed and updated during a treatment process to allow the operator to monitor the progression of the process. The control system may save the monitored data for later use or review by the operator. The saved data may be stored on a removable memory component compatible with a computer or other processing device. Theultrasonicator 10 may also be configured to produce hard copies of the data, such as a paper printout. Theuser interface 16 can also alert the operator, either through an audio or visual indicator such as a beeping sound, flashing light, or message within thedisplay 16 a, if the sample approaches or exceeds any boundaries defining an acceptable range for a sample parameter or characteristic. This combined monitoring/alert feature can be advantageous in embodiments or operating modes that do not use feedback to adjust the treatment protocol during treatment. - Treatment protocols and similar instructions for treating samples may be stored on a
memory component 30 of the control system. In some cases it may be advantageous to store treatment protocols that are relatively specialized to specific uses, sample types, or objectives. The memory component may be fixed to theultrasonicator 10, such as a silicon chip or other hardware component, or may be configured to be readily removable and exchanged for other memory components, e.g., such that the operator can select a memory component comprising treatment protocols pertinent to the needs of the operator. For example, if theultrasonicator 10 is reallocated to a different use, a different memory programmed with protocols or other programs appropriate may be used in place of the original memory component. Similarly, as improved protocols are developed, the operator can also acquire newer memories including these improved protocols. The interchangeable memory component can be a memory card that slides through amemory card slot 28 on theouter housing 18. Alternatively, the memory card can be stored exterior to theouter housing 18, similar to a flash drive. Other suitable interchangeable memory components include compact discs (CDs), compact discs with read-only memory (CD-ROMs), digital versatile discs (DVD), diskettes, flash drives, and memory chips. In one embodiment, theultrasonicator 10 can download treatments protocols from the internet, either onto an interchangeable memory component separable from theultrasonicator 10, directly to a memory component built into theultrasonicator 10, or to an ActiveX or other controller. -
FIG. 1B depicts a cross-sectional view of the interior 44 of thebenchtop ultrasonicator 10 according to an embodiment of the invention. The interior of theultrasonicator 10 can have acavity 32 specially shaped to fit around and hold asuitable sample vessel 26, such as a tube, that contains asample 14. Thecavity 32, or any other suitable sample holder, can be substantially surrounded by a firstfluid bath 34 that is contained within asample tank 36. Thesample tank 36 can be suspended within a coupling medium, such as asecond fluid bath 38, through which anacoustic energy source 40 may transmit acoustic energy to thesample 14. Thesecond fluid bath 38 can be contained within aninterior tank 42 of theultrasonicator 10. Thesample tank 36 andacoustic energy source 40 are capable of moving, and their positions may each be controlled by the control system of theultrasonicator 10. At least a portion of thesample tank 36 can be made of a thin film material having low acoustic absorption and an acoustic impedance similar to the fluid within thesecond fluid bath 38. This portion of thesample tank 36 may be arranged so that it is aligned with theacoustic energy source 40. - In other embodiments, non-fluidic coupling means may be used. The acoustic energy can be transmitted through a viscous (semi-solid)
layer 34 of, for example, silicone gel or rubber, or other material with a gel consistency or rubber consistency, which may optionally be sealed by an impervious membrane such as, for example, a plastic sheet or film, to form a laminate. Exemplary suitable sound-transmitting media are listed in Table 1. This list, however, should not be viewed as comprehensive and exhaustive, and other acoustic coupling media with adequate sound transmission properties may be used instead. In this arrangement, thesample vessel 26 may be pressed against thelayer 34 for more efficient transfer of acoustic energy. In one embodiment, thecover 12 may be configured to provide this pressure by having an interior portion of thecover 12 disposed in contact with thesample vessel 26 when thecover 12 is closed, such that the sample vessel is pressed against thelayer 34. To adjust for different sample vessel sizes while still applying pressure, the interior portion of thecover 12 may be coupled to a spring, bellows-like structure, or any other structure which can be compressed but also resists being compressed.Layer 34 may be free-floating on the fluid surface offluid bath 38 or may be suitably supported in other ways, such as by making the membrane of the laminate oflayer 34 in contact withfluid bath 38 more rigid, by a lattice frame (not shown) or the like. - Table 1 below lists the relative acoustic transmission of various materials relative to water (100%):
-
TABLE 1 Transmission at 1 MHz Material Thickness (in mm) (in % relative to water) No material (water) 100 Acetate 0.13 80 Latex 0.10 50 PET (Mylar) 0.13 90 Silicone 0.13 95 PET (Mylar) 0.05 >95 -
FIG. 2 depicts an electronically controlledultrasonic processing apparatus 100 that includes an ultrasound treatment system and associatedelectronics 200, apositioning system 300 for thesample target 800 being treated, and acontrol system 400 which controls, generates, and modulates the ultrasound signal and controls thepositioning system 300 in a predetermined manner that may or may not include a feedback mechanism. The source ofacoustic energy 230 and thetarget 800 being treated are arranged in afluid bath 600, such as water, such that the source ofacoustic energy 230 is oriented towards thetarget 800. Thetarget 800 may be positioned proximate the surface of thefluid bath 600, above the source ofacoustic energy 230, all being contained within asample processing vessel 500. Any of a multitude ofsensors 700 for measuring processing parameters and/or recognizing sample characteristics can be arranged in or proximate to thefluid bath 600. Atemperature control unit 610 may be used to control the temperature of the fluid in thefluid bath 610. Anoverpressure system 900 can control, for example, cavitation, by maintaining a positive pressure on thetarget 800 and may be adjusted, in a predetermined manner that may or may not include feedback processing, by atarget pressure controller 910 that is connected to thecontrol system 400. -
Target 800 may be a sample, multiple samples, or other device, and may be contained in a variety of sample vessels. Sample vessels are sized and shaped as appropriate for the material to be treated, and can be any of a variety of shapes. For instance, a sample vessel can be an ampoule, vial, pouch, bag, or envelope. These and other sample vessels can be formed from such materials as polyethylene, polypropylene, poly(ethylene terephthalate) (PET), polystyrene, acetate, silicone, polyvinyl chloride (PVC), phenolic, glasses and other inorganic materials, metals such as aluminum and magnesium, and laminates such as polyethylene/aluminum and polyethylene/polyester. Certain configurations of a sample vessel can be made by vacuum forming, injection molding, casting, and other thermal and non-thermal processes. - An ultrasound acoustic field 240 can be generated by the
acoustic energy source 230, for example, a focused piezoelectric ultrasound transducer, into thefluid bath 600. According to one embodiment, theacoustic energy source 230 can be a 70 mm diameter spherically focused transducer having a focal length of 63 mm, which generates an ellipsoidal focal zone approximately 2 mm in diameter and 6 mm in axial length when operated at a frequency of about 1 MHz. Theacoustic energy source 230 is positioned so that the focal zone is proximate the surface of thefluid bath 600. Theacoustic energy source 230 can be driven by an alternating voltage electrical signal generated electronically by thecontrol system 400. - The
positioning system 300 can include at least one motorizedlinear stage 330 that allows the target to be positioned according to a Cartesian coordinate system. Thepositioning system 300 may position and move thetarget 800 relative to thesource 230 in three dimensions (x, y, z) and may optionally move either or both of thetarget 800 and theacoustic energy source 230. Thepositioning system 300 can movetarget 800 during and as part of the treatment process and between processes, as when multiple samples or devices within thetarget 800 are to be processed in an automated or high-throughput format. Thepositioning system 300 may position or move thetarget 800 in a plane transverse to the focal axis of the acoustic energy source 230 (x and y axes). Thepositioning system 300 can position and move thetarget 800 along the focal axis of theacoustic energy source 230 and lift or lower thetarget 800 from or into the fluid bath 600 (z axis). - The
positioning system 300 can also position theacoustic energy source 230 and any or all of thesensors 700 in thefluid bath 600 along the focal axis of theacoustic energy source 230, if thesensors 700 are not affixed in thewater bath 600, as well as lift, lower, or otherwise move theacoustic energy source 230. Thepositioning system 300 also can be used to move other devices and equipment such as detection devices and heat exchange devices from or into the fluid bath 600 (z axis). The linear stages of thepositioning mechanism 330 can be actuated by stepper motors (not shown), which are driven and controlled by electrical signals generated by thecontrol system 400, or other apparatus known to those skilled in the art. -
Sensors 700 can be used prior to, during, or after the acoustic treatment to analyze the samples and/or detect certain physical properties of the sample, for example, by measuring responses to electromagnetic stimulation, such as optical spectroscopy, energy dispersion, scattering absorption, and/or fluorescence emission. Other measurable variables can include electromagnetic properties, such as electrical conductivity, capacitance or inductivity, as well as other physical parameters, such as sample uniformity or pattern analysis. Exemplary sensors may include an additional ultrasonic acoustic transducer suitable to transmit and/or receive an acoustic probe interrogation beam which can be used to assess one or more characteristics, such as the fill level, temperature, cavitation, homogeneity (e.g., presence of absence of particulate matter in the solvent, and/or the size of such particles), volume, etc., of the sample located within the sample vessel. It will be understood by those skilled in the art that the roles of theacoustic energy transducer 230 and the sensor transducer can be reversed in that the sensor transducer may operate to emit the acoustic processing beam while thetransducer 230 performs sensing function. The system may include other types of sensors as well, such as an infrared (IR) temperature sensor to measure the sample temperature. - Interfaces, such as an interface between air and water, cause reflection of an incident ultrasound field. While reflection should be minimized for transmitting acoustic energy to the sample, a signal emitted from the
acoustic energy source 230 or from a separate sensor and reflected by an interface, such as the meniscus of the sample within the sample vessel, can be used to quantify the height and therefore also the volume of the sample. In one embodiment, the sensor may be implemented as an acoustic transducer and emit a short burst of acoustic energy with a duration of 1 ms or less for interrogating the sample. Such short burst is also referred to as a “ping.” As mentioned above, the interrogation burst can be focused on the sample. Due to reflection at the various interfaces encountered by the propagating interrogation sound wave, the sensor receives a return signal after a transit time proportional to the distance between the sensor and the respective interface. For example, it takes a sound wave approximately 10 ms to travel a distance of 1 cm, which is easily resolved by a detection system. The height location of the meniscus of the sample can then be determined from the arrival time difference between the sound wave reflected at the bottom of the sample, and the reflection at the liquid-air interface at the meniscus. The volume of the sample can be taken into consideration when applying acoustic energy for treatment of the sample. - Likewise, air bubbles and particulates can also block or reflect energy transmission through the sample volume. The same principle described above for determining the position of the meniscus can therefore also be used to evaluate the sample volume for the presence or absence of particulates, and/or the size and/or amount of such particles.
- The
control system 400 can include acomputer 410, or other processor or microprocessor, and a user input/output device ordevices 420 such as a keyboard, display, printer, etc. The control system is linked with theultrasound treatment system 200 to drive theacoustic energy source 230, with thepositioning system 300 to drive the stepper motors described above, with one ormore sensors 700 to detect and measure process parameters and/or sample characteristics, and with one or more controllers, such as thetarget pressure controller 910, to alter conditions to which thetarget 800 is exposed. Afluid bath controller 610 could also be linked with thecontrol system 400 to regulate temperature of thefluid bath 600. - The
control system 400 can control and drive thepositioning system 300 with themotion control board 310,power amplifier device 320, andmotorized stage 330, such that thetarget 800 can be positioned or moved during treatment relative to thesource 230 to selectively expose thetarget 800 to acoustic energy. - The
control system 400 can specify a process to be performed upon a sample. In this regard, theultrasound treatment system 200 can include anarbitrary waveform generator 210 that drives anRF amplifier 220, such that theacoustic energy source 230 receives an input. The output signal of theRF amplifier 220 may be conditioned by an impedance matching network and input to theacoustic energy source 230. Thecontrol system 400 can generate a variety of useful alternating voltage waveforms to drive a acoustic energy source. For instance, a high power “treatment” interval consisting of about 5 to 1,000 sine waves, for example, at 1.1 MHz, may be followed by a low power “convection mixing” interval consisting of about 1,000 to 1,000,000 sine waves, for example, at the same frequency. “Dead times” or quiescent intervals of about 100 microseconds to 100 milliseconds, for example, may be programmed to occur between the treatment and convection mixing intervals. A combined waveform consisting of concatenated treatment intervals, convection mixing intervals, and dead time intervals may be defined by the operator or selected from a stored set of preprogrammed waveforms. The selected waveform may be repeated a specified number of times to achieve the desired treatment result. -
FIG. 3 depicts acontrol system 50 similar tocontrol system 400 ofFIG. 2 that includes aprocessor 54, auser interface 56, and amemory 52. Thecontrol system 50 links to actuatingsystems 58 that implement processes specified by thecontrol system 50 and tosensors 60 that may measure processing parameters and/or detect sample characteristics. Actuatingsystems 58 can include positioning systems, ultrasound treatment systems for driving a acoustic energy source, parameter controllers, and any other devices capable of implementing treatment processes, such as those described above in reference toFIG. 1 .Sensors 60 may monitor the impact and efficacy of a treatment process on a sample by detecting visual indicators, temperature, and/or cavitation.Sensors 60 may also detect initial characteristics of the sample like size, solubilization level, and type of sample vessel. - The
memory 52 can include preprogrammed waveforms, protocols, and functions from which theprocessor 54 can select when determining a treatment process. Protocols can include combined or alternating waveforms and any other instructions for anyactuating systems 58. The instructions are preferably predetermined to be advantageous for effecting a specific objective, such as enhancing a reaction, solubilizing the sample, or sterilization, for a specific sample type, which may be dependent on the sample contents, size, temperature, viscosity, level of solubility, vessel, or any other characteristics. Functions can configure a coordinated set of instructions for theactuating systems 58 or select a protocol based on input collected by theprocessor 54. The input can be initial characteristics of the sample and/or process parameters that can be detected bysensors 60 or entered by an operator via theuser interface 42. For instance, a function can, given the volume and contents of a sample, determine the necessary waveform, duty cycle, and length of treatment to mix a sample without significant heating side effects. Other processing variables the function can determine include frequency, energy delivered, burst pattern, intensity, cycles per burst, pulse shape of the waveform, maximum energy level, etc. Theprocessor 54 can select a process to implement based on a combination of user input from theuser interface 42 and/or information from thesensors 60. Theuser interface 42 allows an operator to design and specify a process to be performed upon a sample. In particular, the operator can directly control instructions to actuatingsystems 58, select an option from thememory 52, indicate characteristics of the sample and an objective, or some combination thereof. Theuser interface 42 can also communicate to the operator which treatment process options are available and data detected by thesensors 60. Information from thesensors 60 can be used to configure a treatment process, to select a treatment process, or as feedback to a treatment process. - In one embodiment, measurable or discernible process attributes such as sample temperature, water bath temperature, intensity of acoustic cavitation, or visible evidence of mixing in the sample processing vessel, may be monitored by the
control system 50 and employed in feedback loop to modify automatically during the treatment process any parameters controlled by actuatingsystems 58, such as the treatment waveform or acoustic energy source position. The modification of the treatment waveform may be a proportional change to one or more of the waveform parameters or a substitution of one preprogrammed waveform for another. For instance, if the sample temperature deviates excessively during treatment from a set-point temperature due to absorbed acoustic energy, thecontrol system 50 may proportionally shorten the treatment interval and lengthen the convection mixing interval in response to the discrepancy between the actual and target sample temperatures. Or, alternatively, thecontrol system 50 may substitute one predetermined waveform for another. Thecontrol system 50 may be programmed to terminate a process when one or more of thesensors 60 signal that the desired process result has been attained. - In another embodiment, initial characteristics of the sample may be used by the
control system 50 to assess whether treatment is needed and/or to select a protocol or function optimized for those characteristics. Initial sample characteristics can include sample content, vessel, size, viscosity, temperature, pressure, and position relative to any of theactuating systems 58. In addition, one of thesensors 60 may be adapted to recognize an identifying mark either affixed to the sample or scanned in separately by the operator. Thecontrol system 50 may associate the identifying mark with a corresponding waveform, parameter, protocol, or function, e.g., such that the corresponding aspect of the treatment is set automatically by the controller upon detection of the mark and/or executed automatically upon activation of theultrasonicator 10. If the computer has sufficient control over the effects of theactuating systems 58 to yield the desired objective, the use of a preprogrammed protocol or function may eliminate the need for monitoring sensors during the treatment process. In particular, thecontrol system 50 upon recognition of sufficient sample characteristics can implement a protocol optimized to render the desired effect on that sample while maintaining the sample within certain constraints such as temperature or pressure ranges, without relying on feedback fromsensors 60 while the process is in progress. An embodiment without process monitoring capabilities may be advantageous in cases where a simplified acoustic treatment apparatus is desirable, such as a benchtop apparatus for processing a single sample. - Acoustic treatment may be applied to many types of samples for a variety of purposes. Chemical and biological samples, as well as other types of samples, may be sterilized, mixed, or heated by acoustic treatment. Other applications are described in U.S. Pat. No. 6,719,449 entitled “Apparatus and Method for Controlling Sonic Treatment,” which is hereby incorporated by reference herein. One application in particular is the acoustic treatment of blood or blood-based samples. Treatments can be configured to sterilize a blood sample, to ensure homogeneity of a blood sample, to mix a blood sample with an agent such as an anti-coagulant or a test compound that tests for antibodies, and any other suitable applications that may arise. The
ultrasonicator 10, described above in reference toFIG. 1 , can be adapted for blood treatment as well as for other applications, particularly applications involving small numbers or quantities of samples. In addition to clinical uses, theultrasonicator 10 can be used in hospitals and doctor's offices to prepare or test blood or other samples. - Other applications outside of laboratory settings can utilize the agitating effects of acoustic treatment. Acoustic treatment may be used to break up and/or mix components during food or beverage preparation, to prepare cosmetics, and to homogenize mixtures/suspensions/solutions that separate or otherwise become heterogeneous during storage, such as paint. For instance, acoustic treatment can break up food at the cellular level and/or form emulsions or suspensions. Possible uses include making milkshakes, mayonnaise, purees, foams, sauces, juices (e.g., from fresh produce), ice cream, and butter. Acoustic treatment may be used to prepare cosmetics, such as lipsticks, moisturizers, creams, emollients, liquid soaps, perfumes, astringents, and other suitable colloidal or liquid products, or agitate paint to uniformly mix colors and components. The
ultrasonicator 10 can be adapted for these non-clinical applications and be useful in settings in which customization and/or portability of the device is desired. For food preparation applications, theultrasonicator 10 can be a countertop appliance in consumer or commercial settings, allowing a user to freshly prepare a customized food product. For cosmetic applications, customers in a retail setting can specify and mix colors, scents, and other ingredients for cosmetic products. For paint applications, theultrasonicator 10 can allow a user to prepare paint for use. Due to the size and relative portability of theultrasonicator 10, paint may be mixed at any desired location, for instance, by contractors or painters at a job site. Theultrasonicator 10 may also be used to create small samples of customized paint as an alternative to color swatches. -
FIGS. 4 and 5 depict illustrative processes for treating a pressurized sample with acoustic energy. In particular,FIGS. 4A and SA depict sample vessels for containing the sample and isolating it from other components of an acoustic energy apparatus.FIGS. 4B and 5B depict the sample vessels ofFIGS. 4A and 5A , respectively, after samples have been deposited within the respective vessels.FIGS. 4C and SC depict the samples and sample vessels ofFIGS. 4B and 5B , respectively, after they have been sealed closed and pressurized to pressurize the samples. Methods and apparatus for pressurizing samples within sample vessels are described in more detail below.FIGS. 4D and 5D depict acoustic energy sources applying acoustic energy to the pressurized samples and sealed sample vessels ofFIGS. 4C and 5C , respectively. - Without wishing to be bound by theory, by increasing the pressure of the fluid to be processed, the acoustic energy dose required to cavitate the solution may be greater. This may increase the shear forces consequent to cavitation bubble collapse. This may also result in greater retention time of the sample in the focal zone of the applied acoustic field and/or reduced rate of sample escaping the focal zone. This in turn may effectively increase the collision frequency of the sample with the acoustic bubbles generated by the applied energy and/or increase their resultant shear forces upon bubble collapse. Without wishing to be bound by theory, it is possible that the pressurization of the sample during the ultrasonic treatment may effect a transient increase in the effective viscosity of the sample, and that the acoustic energy has a greater effect in this altered state. This increase in effective strength may result in the observation of finer particle formation, faster tissue homogenization, accelerated lysis of microbial organisms, or otherwise provide for increased precision or speed of processing using the acoustic energy treatment process.
- The sample may include a liquid or solution comprising a sample (e.g., tissue, cell, crystal, buffer, solvent, gel, gum, slurry, blend, single-walled carbon nanotubes, etc., or combination thereof). In certain embodiments, acoustic energy is applied to a solid sample, e.g., in a liquid or gaseous environment, to form particles of the solid material. For example, the application of focused acoustic energy to a solid can cause it to break apart into increasingly smaller fragments than unfocused acoustic energy. Similarly, acoustic energy can agitate sample pieces or particles, inducing collisions that promote further fracturing and/or fragmenting of the solids. In other embodiments, acoustic energy is applied to a liquid sample, thereby inducing the formation of particles. For example, acoustic energy can be applied to, a supersaturated solution, causing a solute to precipitate out of solution. Alternatively, acoustic energy can be applied to a biphasic liquid sample, inducing mixing or the phases and causing the precipitation of a solid. Similarly, acoustic energy can be applied to a hot solution in conjunction with cooling, so that solids that precipitate during cooling are formed into particles of a desired size. The subject systems and methods can be applied to any procedure that results in the formation of a solid material in order to control the size and size distribution of the solid material that forms. Other procedures and desired results are described below.
- An additional benefit for a system is that the entire acoustic circuit, which in some embodiments includes a series of acoustic interfaces such as the transducer-couplant, couplant-vessel, vessel wall, vessel-inner sample, and sample-air/vapor headspace, may be pressurized, which may improve the efficiency of the treatment process. For example, just as a more dense acoustic couplant may transmit acoustic energy more efficiently, a pressurized fluid may transmit acoustic energy more efficiently than a non-pressurized fluid.
-
FIG. 6 depicts an illustrative process for treating a pressurized sample with acoustic energy. In addition,FIG. 6 allows higher pressures to be obtained readily without requiring a special vessel, materials, or a custom design. In particular,FIG. 6A depicts an acoustic energy treatment system which includes anacoustic energy source 6002 coupled via acoupling medium 6004 to asample vessel 6006 containing asample 6008, similar to thesample vessel 4010 depicted inFIG. 4B . The medium 6004 may be a fluid, such as water or buffer, or other compressible medium.FIG. 6B depicts the system of FIG. GA after it has been placed within an air-tight chamber 6010 and pressurized. More particularly, both thesample 6008 and the medium 6004 coupling theacoustic energy source 6002 to thesample vessel 6006 are pressurized due to the elevated atmospheric pressure within thechamber 6010. Methods and apparatus for pressurizing acoustic energy treatment systems are described in more detail below.FIG. 6C depicts the acoustic energy source applyingacoustic energy 6012 via the pressurized medium 6004 to thepressurized sample 6008. - The pressurizing atmosphere may be compressed air, nitrogen, argon, helium, or any other suitable gases or combination thereof. Certain gases may be preferred in certain applications, e.g., for their intrinsic physical properties such as inhibiting biological events, such as nitrogen, or because they may beneficially alter the cavitation threshold energy, such that an altered headspace over a fluidic or partially fluidic/solid sample more readily enables bubble formation and collapse.
- In various embodiments, certain vessel designs may be used to apply pressure to a sample. These vessel designs may allow lab technician to apply pressure to a sample efficiently so that multiple samples can be processed with minimal time and effort. For example, a sample vessel may have a sealing mechanism, for sealing the interior of the sample vessel from the external atmosphere, with which the lab technician, or any other user, may pressurize the sample.
- In one embodiment, an acoustic energy apparatus processes a single sample, e.g., which is inserted into the device. Alternatively, a collection of samples may be inserted into the device, e.g., in a suitable rack, container, or other array for holding the collection of samples. In either scenario, a sealing cap is applied to an individual sample to simultaneously close and pressurize the sample. For example, the sealing cap, while engaging the vessel containing the sample, acts as a piston to pressurize the sample.
FIG. 4C depicts anexemplary sealing cap 4002 for pressurizing asample 4004. In particular, thesealing cap 4002 has abayonet portion 4006 encircled by arim 4008 of approximately the same length as thebayonet portion 4006. The size and shape of therim 4008 is selected such that when thesealing cap 4002 initially engages thesample vessel 4010, therim 4008 seals off exposure of thesample 4004, and the rest of thevessel interior 4012, to the environment external to thevessel 4010. As thesealing cap 4002 is further engaged with thevessel 4010, such that therim 4008 overlaps more of the walls of thesample vessel 4010, thebayonet portion 4006 protrudes into thevessel interior 4012 to increase the pressure within thevessel 4010, thereby pressurizing thesample 4004. Generally, a sealing mechanism may include a displacement portion, such as thebayonet portion 4006, that can protrude into the interior of the sample vessel to decrease the volume of the interior, thereby pressurizing the sample contained within the interior. - Alternatively, a sample may be sealed and then pressurized after sealing. For example,
FIG. 5 depicts an embodiment of avessel 5000 used to apply pressure to sample orsamples 5010. Thevessel chamber 5008 may be accessed throughinput 5004.Input 5004 may be covered by aprotective seal 5006 that is bonded or engaged withvessel chamber 5008.Protective seal 5006 may be reversibly sealable so that sample orsamples 5010 can be introduced intovessel chamber 5008.Protective seal 5006 may be made from any combination of metal, glass, plastic, rubber, plastic film, or any other material suitable to form a bond withvessel chamber 5008 in order to provide a seal, e.g., to prevent sample from exiting the chamber during treatment. In certain embodiments, the seal may be air-tight, water-proof, and/or hermetic.Vessel chamber 5008 may be made from any combination of metal, glass, plastic, rubber, plastic film or any other suitable nonporous material that enablesvessel chamber 5008 to provide a barrier between the sample orsamples 5010 and an external environment. In certain embodiments,protective seal 5006 may compriseport 5002.Port 5002 may be a reversibly sealable port, such as a one-way valve or a rubber septum, for accessing thevessel chamber 5008, e.g., for supplying pressure tovessel chamber 5008, and thus sample orsamples 5010. In one embodiment,port 5002 may be shaped and sized to interface with a needle, such as a hypodermic needle, air injector, cannula, or similar feature. The needle may be used to add or remove materials, such as a sample, a liquid, or a gas, to or from the vessel chamber. In certain embodiments, the vessel chamber may be pressurized (e.g, with air, argon, nitrogen, or another suitable gas) prior to the introduction of the sample or sample medium via a needle. In other embodiments, a needle may be used to inject a liquid or gas intovessel chamber 5008 after introduction of the sample in order to increase the pressure withinvessel chamber 5008. For example, the liquid or gas so introduced may be an inert gas, compressed air, a solvent for the sample, or a suitable treatment medium for the sample. In certain embodiments, the needle may be coupled to a mechanical or manual air pump to increase the pressure of the environment withinvessel chamber 5008. For example, in certain embodiments, the needle may be attached to a bulb. The bulb may be made out of a malleable and durable material such as rubber, plastic, or any other suitable material that is able to deform nondestructively and preferably reversibly when mechanically squeezed. The bulb may be shaped and sized so that the volume of the bulb is greater than the volume of thevessel chamber 5008. In certain embodiments, the bulb may be squeezed or otherwise deformed to inject a liquid or gas intovessel chamber 5008 in order to increase the pressure withinvessel chamber 5008. Thus,vessel 5000 permits sample orsamples 5010 to be exposed to higher pressures in order to facilitate processing of the sample or samples. -
FIG. 7 depicts an embodiment of anautomatic pressurizing device 7002 to increase the pressure of the environment within a sealed vessel chamber, such as the sealed vessels ofFIG. 5 . The device includes aneedle 7006 adapted to reversibly penetrate a seal, such as a rubber septum, agas source 7008, (e.g., a canister of compressed air, nitrogen, argon, or other suitable gas or mixture thereof), and optionally apressure sensor 7004.Pressure sensor 7004 measures the pressure of the environment at the end of theneedle 7006, and may be mechanical or digital. Digital pressure sensors may include piezoresistive semiconductors, microelectromechanical system chips, variable capacitors, or other hardware to suitably detect the pressure of an environment. In embodiments that includepressure sensor 7004, theautomatic pressurizing device 7002 may be configured to automatically pressurize the chamber in an automated fashion when theneedle 7006 is inserted into a sample until a desired level of pressure is reached within the sample chamber. In such embodiments, theautomatic pressurizing device 7002 may be triggered by the force exerted on the needle when it is pushed through a septum, or it may be triggered by force applied to a trigger external to theneedle 7006. The trigger may comprise, for example, aguard 7010 in the vicinity of the needle that contacts the septum as the needle penetrates the septum, or a manual trigger such as a button or lever operated by the user (not shown). Upon activation, theautomatic pressurizing device 7002 may add gas to the chamber until a predetermined pressure is reached, e.g., the pressure of thegas source 7008, or a pressure set by the user or the manufacturer of the device, e.g., via an interface (not shown). In embodiments employing apressure sensor 7004, thepressure sensor 7004 may communicate with a controller that can operate to open or close a pathway between thegas source 7008 and theneedle 7006 so that the correct amount of pressure is reached in a vessel chamber. This communication may occur through electrical means, such as a wire, RFID, or wireless communication, or any other suitable means. - In an exemplary embodiment, a sample vessel may be sealed with a pierceable septum. For example, the sample may be contained within a 13 mm×65 mm round bottom borosilicate glass culture tube (Chromocol, UK) with a screw cap end that is sealed with a Bakelite cap having a rubber septum center. A needle, such as a 22-gauge, 1.5-inch hypodermic needle, can be inserted through the septum to apply elevated pressure through the needle. The pressure equilibrates through the needle bore, pressurizing the interior of the tube and the sample. High-intensity focused ultrasound (“HIFU”) acoustic energy (as used with the Covaris, Woburn, Mass., USA S-series instruments) can then be applied to process the sample in the tube. The pressure may be allowed to equilibrate to atmospheric pressure, and then the sample may be removed from the tube, e.g., by inserting the needle further into the tube to collect the fluidic sample in a manual manner. Alternatively, the pressure in the tube may be used to eject the sample, e.g., through a cannula inserted through the septum into the sample. All or part of the above-described process, including sample preparation, sealing, pressurization, treatment, depressurization, and sample removal, may be readily automated. In some such embodiments, the needle, though inserted into the sample chamber, is not in the focused acoustic energy field. In other embodiments, the needle may be located in the acoustic focal zone, e.g., as a nucleation site for cavitation events.
- In another embodiment, a single sample or a batch of single samples are inserted into an apparatus and pressurized prior to the application of acoustic energy. For example, a microtitre plate with 96 350-microliter sample wells may be loaded with 100 microliters per well. The open plate may be inserted into an apparatus which allows the atmosphere at the fluid/air interface of the samples to be elevated prior to an acoustic dose. Alternatively, the plate may be sealed prior to treatment with a lid that either pressurizes each well (e.g., via a piston-type approach, as discussed above) or allows the sealed compartment to be pressurized (e.g., through a septum or one-way valve, as discussed above).
- In another embodiment, a sample vessel may have one or more flexible or elastic walls to allow the volume of the interior of the sample vessel to decrease, thereby increasing the pressure. One of the walls, or portion of a wall, of the sample vessel may be sufficiently pliable to allow increased pressure external to the pliable wall to be transmitted to the contained sample. For example, a plastic bag, a balloon, a test tube having a slidably engaged piston plunger, or other sample vessel having a deformable structure may shrink in volume when placed in an elevated pressure atmosphere, thereby pressurizing the sample, even though the sample remains sealed from the external environment. Alternatively or in addition, an external force may be applied to the sample vessel to shrink the volume of the vessel interior. The application of the external force may be automated or may comprise a user of an acoustic treatment apparatus physically manipulating the sample vessel to deform its structure.
-
FIG. 8 depicts another embodiment of avessel 8000 used to apply pressure to sample orsamples 8010. Thevessel chamber 8008 may be accessed throughinput 8002.Vessel chamber 8008 may be made from any combination of metal, glass, plastic, rubber, plastic film or any other suitable nonporous material that enablesvessel chamber 8008 to provide a barrier between the sample orsamples 8010 and an external environment.Input 8002 may be shaped and sized to interface withplunger 8004.Plunger 8004 may comprise astopper 8006 coupled to astem 8007. The length ofstem 8007 ofplunger 8004 may be equal to or greater in length than the length ofvessel chamber 8008, but is typically sufficiently long to facilitate movement of thestopper 8006 through a range of positions within the vessel chamber.Stopper 8006 ofplunger 8004 may be shaped and sized to form a seal withinput 8002.Stopper 8006 ofplunger 8004 may be made out of rubber, plastic, or any other suitable material to form a seal withinput 8002. The seal is preferably airtight.Stem 8007 ofplunger 8004 may be made out of glass, plastic, or any other suitable material that allows a user or an automated device to employstem 8007 ofplunger 8004 and deliver a downward force to reduce the volume of thevessel chamber 8008, thereby increasing the pressure in the chamber.Stem 8007 ofplunger 8004 may also be shaped and sized so that it may be employed to apply an upward force to removestopper 8006 from thevessel chamber 8008 so that the pressure withinvessel chamber 8008 may be reduced and/or the vessel chamber can be accessed. Thus,vessel 8000 may be employed to expose sample orsamples 8010 to higher pressures in order to facilitate processing of the sample or samples. -
FIG. 9 depicts another embodiment of avessel 9000 used to apply pressure to sample orsamples 9010. Sample orsamples 9010 may be placed insidevessel chamber 9008 throughinput port 9002.Vessel chamber 9008 may be made out of a substantially malleable yet durable material such thatvessel chamber 9008 deforms nondestructively when physically manipulated and provides a barrier between the sample orsamples 9010 and an external environment. Suitable materials include rubber, metal foil (e.g., aluminum), plastic, or any combination thereof.Vessel 9000 also includes bottom 9006.Bottom 9006 may be shaped and sized to fit into a sample holding device such as a 96-well plate, or any suitable sample holding device. In certain embodiments,input port 9002 may be shaped and sized to be clamped byclip 9012.Clip 9012 may be made out of plastic, rubber, or any material suitable to clampinput port 9002.Clip 9012 may be shaped and sized to slide up and down the body of thevessel chamber 9008 and hold a fixed position after movement.Clip 9012 may be removable (e.g., to accessvessel chamber 9008 through input port 9002), and preferably sealsvessel chamber 9008, e.g., for treatment, such as with an airtight seal. In a variant embodiment,input port 9002 may be located on the side of thevessel 9000, such that theclip 9012 slides up and down the body and over theport 9002, thus reversibly sealing thevessel chamber 9008. By manipulatingclip 9012, parts of thevessel body 9008 may deform nondestructively. In certain embodiments, manipulatingclip 9012 may reduce the volume ofvessel chamber 9008. By reducing the volume ofvessel chamber 9008 in this manner, thevessel chamber 9008 may be pressurized. Thus,vessel 9000 may be employed to expose sample orsamples 9010 to higher pressures in order to facilitate processing of the sample or samples. - In another embodiment, focused acoustic energy is applied to a flowing fluid stream exposed to elevated pressure prior to and/or during acoustic energy treatment. This embodiment may form part of a flow-through or intermittent flow system that may be employed in the production of fine chemicals, food products, pharmaceuticals, cosmetics, and in other manufacturing settings. For example, this system may include a cell with a quartz window for acoustic energy transmission. In another example, the flowing fluid stream passes through a constriction which elevates the pressure on the fluid in the region preceding the constriction. The entire transducer may be contained within the flowing stream of a sample to be processed that is intermittently pressurized. In certain embodiments, a focused acoustic energy apparatus may synchronize the flow with the acoustic dose to achieve the desired result (e.g., crystal dissolution, sonocrystallization, and the like). This continuous flow process may also be automated.
- Various embodiments of the present invention will be further understood by reference to the following non-limiting examples.
- Long nucleic acid strands, such as genomic DNA, are too large to use in certain applications without first shearing the strands to fragments of smaller size, e.g., for library construction or for certain methods of DNA sequencing. Cleaving the DNA strands to fragments with lengths of 500 base pairs (“bp”), 200 bp, or less can thus be an important step in the preparation of DNA samples.
- In this example, 20 μg of lambda DNA in 400 μl of 1 mM EDTA was placed in 13×65 mm round bottom glass tubes. Each tube was then treated in an S2 turbo at 10% duty cycle, 10 intensity, and 200 cycles/burst for 6 minutes in the power track mode with a bath temperature of 7-8° C. The treatments were conducted at or near the following pressures: 14.7 pounds per square inch (“psi”), 29 psi, 44 psi, and 57 psi. The sizes of the DNA fragments were then determined by running 22 Al aliquots from each tube on a 0.7% agarose gel along with size markers. The DNA was visualized with ethidium bromide staining. The size of the starting lambda DNA was 48,502 bp. After treatment at 14.7 psi, the majority of the DNA fragments were in the 100 to 650 bp size range. After treatment at 29 psi, the majority of the DNA fragments were in the 100 to 500 bp size range; and at pressures of 44 and 57 psi, the majority of the DNA fragments were in the 100 to 375 bp range, as summarized in Table 1 below.
-
TABLE I Ranges of sizes for the majority of DNA fragments after treatment at various pressures Pressure DNA Fragment Sizes 14.7 psi 100-650 bp 29 psi 100-500 bp 44 psi 100-375 bp 57 psi 100-375 bp - The DNA shearing described in example one may also be controlled by the variation of the pressure level, e.g., 1, 2, and 3 atmospheres (“atms”) and beyond. A dose response was observed by variations in the pressure of the sample while keeping the treatment duration, temperature, and acoustic dose constant
- In this example, 20 μg of lambda DNA in 400 μl of 1 mM EDTA was placed into 13×65 mm round bottom glass tubes. Each tube was then treated as in Example One, except that only pressures of 14.7 psi and 44 psi were used. Aliquots of 22 Al were removed after 1, 3, and 6 minutes of treatment. The size of DNA fragments was determined by agarose gel electrophoresis as in Example One. At 14.7 psi, the size ranges for the majority of the DNA fragments at various treatment durations are summarized by Table 2 below.
-
TABLE 2 Range of sizes for the majority of DNA fragments after treatment at various durations and pressures DNA Fragment DNA Fragment Sizes with Sizes with Treatment Duration Treatment at 14.7 psi Treatment at 44 psi 60 seconds 200-2,000 bp 150-1,000 bp 180 seconds 100-1,000 bp 100-500 bp 360 seconds 100-700 bp 100-375 bp - Particle generation of hydroxyapatite (HAP) may be faster and result in smaller particles. Treating crystals while at elevated pressures may produce more and smaller fragments at a faster rate.
- A suspension of ceramic hydroxyapatite particles was prepared by placing 3.1 mg of ceramic hydroxyapatite particles (20 Am from Bio-Rad, Hercules, Calif.) in a 13×65 mm glass round bottom screw cap tube and adding 2.0 ml of 50 mM trisodium citrate. The tube was capped and immediately processed in a Covaris S2 instrument with the following treatment parameters: power track mode,
water bath temperature 8 degree C., 10% duty cycle, 10 intensity, 200 cycles per burst, and 30 seconds of treatment. The contents of the glass tube were then transferred to a cuvette and left undisturbed for 300 seconds to allow any large particles present to settle out. The cuvette was then placed in a spectrophotometer and the absorbance at 600 nm measured. The absorbance is due to light scatterings by the small particles that remain in suspension and thereby provides a measure of the amount of small particles generated by the acoustic treatment. - For the elevated pressure experiments, the cap of the 13×65 mm tube was fitted with a tubing connection and a section of Tygon tubing that connected the glass tube to a pressure regulator that was, in turn, connected to a compressed air supply. Control experiments run at atmospheric pressure (approximately 15 psi) had an absorbance reading of 0.699 after 30 second of the above treatment. Experiments at elevated pressure were run at approximately 45 psi with compressed air and had an absorbance reading of 1.442 after 30 seconds of acoustic treatment. Thus the rate of fragmentation during the first 30 seconds of acoustic treatment was doubled when the pressure was increased to 45 psi.
- Yeast spores are more readily disrupted with the elevated pre-pressurization prior to application of focused acoustic energy. This pressurization may render the spores more susceptible to the effects of HIFU. Treating yeast while at elevated pressures may increase the lysis of yeast cells.
- Yeast cells from a frozen stock were suspended in 1.5 ml of 33 mM potassium phosphate pH 7.5 buffer in a 13×65 mm glass round bottom screw cap tube. 25 μl of a lyticase (Sigma, St. Louis, Mo.) stock (500 units/ml in cold distilled H20 made fresh daily) was added to the tube. The tube was capped and processed with a Covaris S2 instrument. The acoustic treatments were run in the power tracking mode with a water bath temperature of 26+/−1 degree C. The control sample was run at atmospheric pressure with brief low power acoustic mixing to keep the yeast cells in suspension. The low power treatment parameters were as follows: 1% duty cycle, 3 intensity, 200 cycles per burst, for 10 seconds; then 1% duty cycle, 0.1 intensity, 50 cycles per burst, for 50 seconds. These steps were repeated to generate the selected total treatment time. The parameters for high power treatment were: 20% duty cycle, 10 intensity, 200 cycles per burst, 30 seconds; then 1% duty cycle, 0.1 intensity, 50 cycles per burst 60 seconds; and again 20% duty cycle, 10 intensity, 200 cycles per burst, 30 seconds. For the elevated pressure experiment the pressure in the tube was increased to 45 psi as described in Example 3 above. 60 μl aliquots were removed from the glass tubes at selected time intervals and transferred to a 0.65 ml microcentrifuge tube. The tube was centrifuged at 10,000 rpm for 1.5 minutes to pellet the cells; 50 μl of the supernatant was assayed for soluble protein using the Bradford dye binding assay (the absorbance at 595 nm is proportional to the protein concentration).
-
FIG. 10 depicts a graph showing absorbance of yeast samples after acoustic treatment at various durations, pressures, and acoustic intensities. The line labeled “Aco. Mix” represents results from using an acoustic mix that was low power and sub-cavitation energy to gently resuspend yeast during incubation. The line labeled “15 psi” represents results from using a high power focused acoustic field at atmospheric pressure. The line labeled “45 psi” represents results from using a high power focused acoustic field at elevated pressure. - After two minutes of treatment, as shown in the graph depicted in
FIG. 10 , the control had a protein assay absorbance of 0.049; the high power acoustic treatment at atmospheric pressure (15 psi) had an absorbance of 0.174; and the high power acoustic treatment at 45 psi had an absorbance of 0.415. High power acoustic treatment at atmospheric pressure resulted in a 3.5-fold increase in the protein assay absorbance over the control. High power acoustic treatment at elevated pressure, namely 45 psi, resulted in an 8-fold increase in the protein assay absorbance over the control and a 2-fold increase over the high power treatment at atmospheric pressure, and appeared to reach end-point in 12 minutes. - Those skilled in the art will know, or be able to ascertain using no more than routine experimentation, many equivalents to the embodiments and practices described herein. Accordingly, it will be understood that the invention is not to be limited to the illustrative embodiments disclosed herein. Other illustrative devices, systems, methods, applications, and features of the invention are described in the following documents which are hereby incorporated by reference herein:
- 1. U.S. Pat. No. 6,719,449 entitled “Apparatus and Method for Controlling Sonic Treatment”
- 2. U.S. application Ser. No. 11/001,988, filed Dec. 2, 2004, and entitled “Apparatus and Methods for Sample Preparation”
- 3. U.S. Pat. No. 6,948,843 entitled “Method and apparatus for acoustically controlling liquid solutions in microfluidic devices”
- The first-named reference above discloses apparatuses and methods for exposing a sample to acoustic energy and for selectively controlling acoustic energy and/or the location of the sample relative to acoustic energy that may be used in conjunction with the invention disclosed herein. In particular, the first reference discloses various acoustic energy sources, electronics and waveforms, positioning systems, sensors, control systems, sample vessels, materials for treatments, and applications of acoustic treatment.
- The second-named reference above discloses systems, methods, and devices relating to processing a sample that may be used in conjunction with the invention disclosed herein. In particular, the second reference discloses various sample vessels and systems and methods for collecting, stabilizing, fragmenting and/or analyzing samples.
- The third-named reference above discloses systems, methods, and devices relating to coupling acoustic energy to a sample vessel to lower acoustic energy requirements to obtain desired process results, such as mixing.
- The subject matter discussed above can readily be adapted for use in the systems and methods disclosed in the above references. It should be noted that Applicants consider all operable combinations of the disclosed illustrative embodiments to be patentable subject matter including combinations of the subject matter disclosed in the above references.
Claims (16)
1-34. (canceled)
35. A method of processing a sample held within a vessel, the method comprising:
subjecting the sample to pressurization such that a pressure within the vessel is greater than a pressure outside of the vessel;
providing focused acoustic energy to the sample held within the vessel, the focused acoustic energy having a frequency of between about 100 kilohertz and about 100 megahertz and a focal zone having a width of less than about 2 centimeters, and the focused acoustic energy originating from an acoustic transducer exterior to the vessel; and
inducing cavitation within the vessel at a location proximate to the sample held within the vessel.
36. The method of claim 35 , wherein the pressure within the vessel is greater than standard atmospheric pressure.
37. The method of claim 35 , wherein pressurization of the sample lowers a threshold of acoustic energy required for cavitation within the vessel to occur.
38. The method of claim 35 , wherein subjecting the sample to pressurization comprises adding at least one of compressed air, nitrogen, argon, helium and inert gas to a space within the vessel.
39. The method of claim 35 , wherein subjecting the sample to pressurization comprises sealing the vessel with a cover, piercing the cover with a needle, and delivering at least one fluid through the needle into the vessel.
40. The method of claim 35 , wherein subjecting the sample to pressurization comprises reducing a volume of the vessel.
41. The method of claim 40 , wherein subjecting the sample to pressurization comprises sealing the vessel with a plunger and moving the plunger in a direction that reduces the volume of the vessel.
42. The method of claim 40 , wherein the vessel comprises a deformable container and subjecting the sample to pressurization comprises sealing the vessel with a clip and moving the clip in a direction that reduces the volume of the vessel.
43. The method of claim 35 , wherein providing focused acoustic energy to the sample sterilizes the sample.
44. An apparatus for treating a sample using acoustic energy, the apparatus comprising:
a vessel constructed and arranged to hold the sample and to subject the sample to pressurization such that a pressure within the vessel is greater than a pressure outside of the vessel; and
an acoustic energy source comprising a transducer that is spaced from and exterior to the vessel, the transducer being adapted to generate acoustic energy for forming at least one focused acoustic field having a frequency of between about 100 kilohertz and about 100 megahertz and a focal zone having a width of less than about 2 centimeters.
45. The apparatus of claim 44 , wherein the vessel comprises a cover configured to form an air-tight seal between a space within the vessel and outside of the vessel.
46. The apparatus of claim 45 , wherein the cover comprises a pierceable septum that allows for delivery of at least one fluid into the space within the vessel for pressurization of the sample.
47. The apparatus of claim 45 , wherein the cover comprises a plunger movable in a direction that reduces a volume of the vessel for pressurization of the sample.
48. The apparatus of claim 44 , wherein the vessel comprises a deformable container.
49. The apparatus of claim 48 , further comprising a clip constructed and arranged to seal the vessel and to move in a direction that reduces a volume of the vessel.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/711,807 US20130177922A1 (en) | 2006-08-01 | 2012-12-12 | Methods and apparatus for treating samples with acoustic energy |
US14/856,029 US20160002708A1 (en) | 2006-08-01 | 2015-09-16 | Methods and apparatus for treating samples with acoustic energy |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83497906P | 2006-08-01 | 2006-08-01 | |
US92333507P | 2007-04-13 | 2007-04-13 | |
US11/888,708 US8353619B2 (en) | 2006-08-01 | 2007-08-01 | Methods and apparatus for treating samples with acoustic energy |
US13/711,807 US20130177922A1 (en) | 2006-08-01 | 2012-12-12 | Methods and apparatus for treating samples with acoustic energy |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/888,708 Continuation US8353619B2 (en) | 2006-08-01 | 2007-08-01 | Methods and apparatus for treating samples with acoustic energy |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/856,029 Continuation US20160002708A1 (en) | 2006-08-01 | 2015-09-16 | Methods and apparatus for treating samples with acoustic energy |
Publications (1)
Publication Number | Publication Date |
---|---|
US20130177922A1 true US20130177922A1 (en) | 2013-07-11 |
Family
ID=38997723
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/888,708 Active 2030-02-23 US8353619B2 (en) | 2006-08-01 | 2007-08-01 | Methods and apparatus for treating samples with acoustic energy |
US13/711,807 Abandoned US20130177922A1 (en) | 2006-08-01 | 2012-12-12 | Methods and apparatus for treating samples with acoustic energy |
US14/856,029 Abandoned US20160002708A1 (en) | 2006-08-01 | 2015-09-16 | Methods and apparatus for treating samples with acoustic energy |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/888,708 Active 2030-02-23 US8353619B2 (en) | 2006-08-01 | 2007-08-01 | Methods and apparatus for treating samples with acoustic energy |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/856,029 Abandoned US20160002708A1 (en) | 2006-08-01 | 2015-09-16 | Methods and apparatus for treating samples with acoustic energy |
Country Status (2)
Country | Link |
---|---|
US (3) | US8353619B2 (en) |
WO (1) | WO2008016691A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100132438A1 (en) * | 2008-11-28 | 2010-06-03 | Roche Diagnostics Operations, Inc. | System and method for the automated processing of fluids, method for determining the matching of objects |
US20140238110A1 (en) * | 2013-02-27 | 2014-08-28 | Ethicon, Inc. | Leakage detection in a medical device |
US9320995B2 (en) | 2013-09-17 | 2016-04-26 | Covaris, Inc. | Method and apparatus for processing sample material |
US20160243488A1 (en) * | 2013-10-14 | 2016-08-25 | Coldharbour Marine Limited | Apparatus and method |
WO2019183130A1 (en) * | 2018-03-19 | 2019-09-26 | Trustees Of Boston University | Systems, devices, and methods for ultrasonic agitation mediated kinetic release testing of compounds |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7981368B2 (en) | 1998-10-28 | 2011-07-19 | Covaris, Inc. | Method and apparatus for acoustically controlling liquid solutions in microfluidic devices |
US7687039B2 (en) * | 1998-10-28 | 2010-03-30 | Covaris, Inc. | Methods and systems for modulating acoustic energy delivery |
US6948843B2 (en) | 1998-10-28 | 2005-09-27 | Covaris, Inc. | Method and apparatus for acoustically controlling liquid solutions in microfluidic devices |
EP1125121B1 (en) * | 1998-10-28 | 2007-12-12 | Covaris, Inc. | Apparatus and methods for controlling sonic treatment |
WO2005056748A1 (en) * | 2003-12-08 | 2005-06-23 | Covaris, Inc. | Apparatus and methods for sample preparation |
US7757561B2 (en) * | 2005-08-01 | 2010-07-20 | Covaris, Inc. | Methods and systems for processing samples using acoustic energy |
US8353619B2 (en) | 2006-08-01 | 2013-01-15 | Covaris, Inc. | Methods and apparatus for treating samples with acoustic energy |
US8702836B2 (en) | 2006-11-22 | 2014-04-22 | Covaris, Inc. | Methods and apparatus for treating samples with acoustic energy to form particles and particulates |
CA2703597A1 (en) * | 2007-10-25 | 2009-04-30 | Novartis Ag | Powder conditioning of unit dose drug packages |
US8999704B2 (en) | 2008-06-24 | 2015-04-07 | Covaris, Inc. | Method and apparatus for headspace control in acoustic processing of samples |
EP2304405B1 (en) * | 2008-06-24 | 2021-04-28 | Covaris, Inc. | Method and apparatus for treatment enhancement in acoustic processing of samples |
DE102008030213A1 (en) * | 2008-06-25 | 2009-12-31 | Theuer, Axel E., Prof. Dr.-Ing. habil. | Device for destruction of tumor cells and tumor tissue |
WO2010077980A1 (en) * | 2008-12-16 | 2010-07-08 | Aardvark Medical, Inc. | Methods and systems for delivery of fluids, aerosols and acoustic energy to tissue surfaces, cavities and obstructed passages such as intranasal ostia |
AU2010237530B2 (en) | 2009-04-14 | 2016-04-21 | Biocartis Nv | HIFU induced cavitation with reduced power threshold |
US20110177576A1 (en) * | 2010-01-21 | 2011-07-21 | Tissue Regenerationtechnologies, Llc. | Shock wave cell treatment device and method to enhance cell replication |
US9192719B2 (en) * | 2010-11-01 | 2015-11-24 | Medtronic, Inc. | Implantable medical pump diagnostics |
US8709359B2 (en) | 2011-01-05 | 2014-04-29 | Covaris, Inc. | Sample holder and method for treating sample material |
CN103079528A (en) * | 2011-03-16 | 2013-05-01 | 安德烈·亚历山大罗维奇·戈特洛夫 | Method for simultaneously processing and producing quantities of an emulsive cosmetic agent |
US20130026669A1 (en) * | 2011-07-14 | 2013-01-31 | Covaris, INC | Systems and methods for preparing nanocrystalline compositions using focused acoustics |
RU2479346C1 (en) * | 2011-08-29 | 2013-04-20 | Андрей Александрович Геталов | Method of simultaneous ultrasound cavitation processing of different-composition media |
US9951990B2 (en) * | 2011-09-06 | 2018-04-24 | RheaVita B.V. | Method and system for freeze-drying injectable compositions, in particular pharmaceutical compositions |
WO2013056062A1 (en) | 2011-10-13 | 2013-04-18 | Microsonic Systems Inc. | Apparatus and method for using ultrasonic radiation for controlled fragmentation of chains of nucleic acids |
WO2014150290A1 (en) * | 2013-03-15 | 2014-09-25 | Theranos, Inc. | Devices, systems and methods for sample preparation |
US9359632B2 (en) | 2013-03-15 | 2016-06-07 | Theranos, Inc. | Devices, systems and methods for sample preparation |
CA2854704A1 (en) * | 2013-06-19 | 2014-12-19 | Weatherford/Lamb, Inc. | Method and apparatus for measuring deformation of non-metallic materials |
US10398843B2 (en) * | 2013-10-15 | 2019-09-03 | Covaris, Inc. | Apparatus and method for acoustic treatment and delivery of samples for medical treatment |
CA2951514A1 (en) | 2014-06-18 | 2015-12-23 | Clear Gene, Inc. | Methods, compositions, and devices for rapid analysis of biological markers |
US10058860B2 (en) | 2014-08-05 | 2018-08-28 | Covaris, Inc. | Methods and apparatuses for acoustic treatment of samples |
EP3194594A4 (en) | 2014-08-15 | 2017-08-09 | Counsyl, Inc. | High-throughput sample processing systems and methods of use |
US10093955B2 (en) | 2014-10-14 | 2018-10-09 | Covaris, Inc. | Acoustic energy mediation of genetic fragmentation |
US10280395B2 (en) * | 2014-12-24 | 2019-05-07 | Covaris, Inc. | Acoustic energy treatment using phase change couplant |
US9987416B2 (en) * | 2015-01-09 | 2018-06-05 | BioQuiddity Inc. | Sterile assembled liquid medicament dosage control and delivery device |
WO2016145039A1 (en) | 2015-03-10 | 2016-09-15 | Rubicon Genomics, Inc. | Enhanced fragmentation and repair of nucleic acids |
CN105238660B (en) * | 2015-08-19 | 2020-04-14 | 欧永强 | Frequency conversion ultrasonic wine aging device |
US9776107B1 (en) * | 2016-06-16 | 2017-10-03 | Wichita State University | System and method for recycling of pre-impregnated composite fibers |
PT109563B (en) | 2016-08-02 | 2020-09-23 | Hovione Farmaciencia Sa | METHOD FOR IMPROVING THE DEVELOPMENT AND VALIDATION OF ANALYTICAL AND SAMPLE PREPARATION METHODS FOR ACCURATE AND REPRODUCTIVE MEASUREMENT OF PARTICLE SIZE |
US10960370B2 (en) | 2017-06-07 | 2021-03-30 | Omni International, Inc. | Ultrasonic homogenization device with closed-loop amplitude control |
KR102121602B1 (en) * | 2018-06-27 | 2020-06-10 | 주식회사 티아라줄기세포연구소 | Crushed Stem Cell Extract(Shelled Stem Cell) Manufacturing Method Using Mass Culture Medium Composition Method and Constituent 3-low Extracting Method and A Treating Composition for Anti-Inflammatory and A Treating Composition for Cell Regeneration |
US11338082B2 (en) | 2019-09-04 | 2022-05-24 | BloQ Pharma, Inc. | Variable rate dispenser with aseptic spike connector assembly |
CA3178144A1 (en) * | 2020-04-01 | 2021-10-07 | Evident Canada, Inc. | Apparatus for couplant management |
CN111438764B (en) * | 2020-04-23 | 2021-12-28 | 杭州电子科技大学 | Device and method for processing continuous porous aluminum foil by utilizing ultrasonic waves |
US20220121190A1 (en) * | 2020-10-16 | 2022-04-21 | Bell Textron Inc. | Methods and systems for performing non-destructive testing |
US11839905B2 (en) * | 2021-11-04 | 2023-12-12 | Ekhoo, LLC | Vibrating base assembly for cleaning contact lenses |
WO2023213793A1 (en) * | 2022-05-02 | 2023-11-09 | Inveox Gmbh | Methods and systems for histological sample preparation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3080299A (en) * | 1960-07-05 | 1963-03-05 | Bendix Corp | Accelerating microorganism physiological activity and reproduction |
US5659173A (en) * | 1994-02-23 | 1997-08-19 | The Regents Of The University Of California | Converting acoustic energy into useful other energy forms |
US20020009015A1 (en) * | 1998-10-28 | 2002-01-24 | Laugharn James A. | Method and apparatus for acoustically controlling liquid solutions in microfluidic devices |
US6719449B1 (en) * | 1998-10-28 | 2004-04-13 | Covaris, Inc. | Apparatus and method for controlling sonic treatment |
Family Cites Families (115)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1734975A (en) * | 1927-09-02 | 1929-11-12 | Alfred L Loomis | Method and apparatus for forming emulsions and the like |
US2447061A (en) * | 1945-07-18 | 1948-08-17 | Cambridge Thermionic Corp | Piezoelectric system |
US2424375A (en) * | 1946-02-21 | 1947-07-22 | Ultrasonic Corp | Modulator for sound waves |
US2578505A (en) | 1948-03-02 | 1951-12-11 | Sperry Prod Inc | Supersonic agitation |
US2585103A (en) * | 1948-03-08 | 1952-02-12 | Otis A Brown | Apparatus for ultrasonic treatment of liquids |
US2565159A (en) * | 1949-04-21 | 1951-08-21 | Brush Dev Co | Focused electromechanical device |
US2632634A (en) * | 1950-09-23 | 1953-03-24 | Brush Dev Co | Electroacoustic device |
US2738172A (en) * | 1952-11-28 | 1956-03-13 | Nat Dairy Res Lab Inc | Apparatus for treatment of products with ultrasonic energy |
US2916265A (en) | 1954-11-22 | 1959-12-08 | Ultrasonic Dev Inc | Ultrasonic apparatus |
US2864592A (en) | 1955-03-07 | 1958-12-16 | Bendix Aviat Corp | Liquid-vibrating apparatus |
US2855526A (en) * | 1955-10-24 | 1958-10-07 | Aeroprojects Inc | Apparatus for generating ultrasonic energy of high intensity |
US2950725A (en) * | 1958-03-26 | 1960-08-30 | Detrex Chem Ind | Ultrasonic cleaning apparatus |
US3066686A (en) | 1960-05-10 | 1962-12-04 | Bendix Corp | Sonic treating apparatus |
US3194640A (en) * | 1961-02-10 | 1965-07-13 | Nesh Florence | Use of ultrasound to induce crystal rearrangements and phase transitions |
FR1532203A (en) | 1961-10-31 | 1968-07-12 | Process for the treatment of bodies by sound or ultrasound and device for its implementation | |
GB1105962A (en) | 1964-06-29 | 1968-03-13 | Ilford Ltd | Colour photographic materials and processes |
US3292910A (en) | 1964-11-10 | 1966-12-20 | Stanford Research Inst | Ultrasonic concentrator |
US3396286A (en) * | 1965-01-21 | 1968-08-06 | Linden Lab Inc | Transducer assembly for producing ultrasonic vibrations |
US3481186A (en) | 1965-03-17 | 1969-12-02 | Int Harvester Co | Methods of and systems for effecting the nondestructive analysis of materials |
US3352311A (en) * | 1965-04-22 | 1967-11-14 | Francis J Murphy | Vibra-watch and jewelry cleaner |
US3503805A (en) * | 1967-01-10 | 1970-03-31 | Howard R Denyes | Method and apparatus for cleaning roller assemblies |
US3596883A (en) * | 1968-11-08 | 1971-08-03 | Branson Instr | Ultrasonic apparatus |
US3614069A (en) * | 1969-09-22 | 1971-10-19 | Fibra Sonics | Multiple frequency ultrasonic method and apparatus for improved cavitation, emulsification and mixing |
US3604270A (en) * | 1970-01-05 | 1971-09-14 | Richard A Falk | Sampling lance with metal tube |
US3837805A (en) * | 1971-01-15 | 1974-09-24 | Wave Energy Systems | Apparatus for continuous sterilization at low temperature |
US3743523A (en) * | 1971-08-04 | 1973-07-03 | A Bodine | Method for the sonic treating of food material |
US3807704A (en) * | 1972-11-13 | 1974-04-30 | Phillips Petroleum Co | Dispersing and mixing apparatus |
US3851861A (en) * | 1973-09-18 | 1974-12-03 | Thurman Mfg Co | Ultrasonic cleaning device with temperature responsive cut-off |
US3876980A (en) * | 1973-11-05 | 1975-04-08 | Products Of Information Techno | Vehicle location systems |
US4028933A (en) * | 1974-02-15 | 1977-06-14 | The Board Of Trustees Of Leland Stanford Junior University | Acoustic microscope |
US3972614A (en) * | 1974-07-10 | 1976-08-03 | Radiometer A/S | Method and apparatus for measuring one or more constituents of a blood sample |
US3919558A (en) | 1974-11-04 | 1975-11-11 | Gen Electric | Hot sub-stage for a scanning electron microscope |
DE2557668A1 (en) | 1975-12-20 | 1977-06-30 | Innotec Oy | Short term ultrasonic homogenisation of liquid in stages - each emitter having two heads to vibrate two stages |
JPS51112792A (en) | 1976-03-16 | 1976-10-05 | Elliott Herbert J | Method of pelletizing sulfur |
USRE31779E (en) | 1976-03-26 | 1984-12-25 | Alcide Corporation | Germ-killing composition and method |
US4193818A (en) * | 1978-05-05 | 1980-03-18 | American Sterilizer Company | Combined ultrasonic cleaning and biocidal treatment in a single pressure vessel |
US4307964A (en) | 1981-02-25 | 1981-12-29 | The United States Of America As Represented By The Secretary Of The Interior | System for maintaining high resonance during sonic agglomeration |
US4488816A (en) | 1982-12-27 | 1984-12-18 | Vota Mario F | Apparatus for the generation and the automatic control of ultrasonic waves in the treatment of fluids |
US4571087A (en) * | 1983-03-22 | 1986-02-18 | Board Of Regents, University Of Texas System | Array sonicator apparatus for automated sample preparation |
US4541281A (en) * | 1983-04-03 | 1985-09-17 | Noriyoshi Chubachi | Ultrasonic microscope system |
FR2574548B1 (en) * | 1984-12-10 | 1987-07-31 | Alsthom Atlantique | DEVICE FOR MEASURING THE CONTENT OF A LIQUID IN CAVITATION GERM |
US4926871A (en) * | 1985-05-08 | 1990-05-22 | International Biomedics, Inc. | Apparatus and method for non-invasively and automatically measuring the volume of urine in a human bladder |
US5086810A (en) * | 1985-10-28 | 1992-02-11 | Milliken Research Corporation | Ultra-sonic reed cleaning system |
GB8529446D0 (en) | 1985-11-29 | 1986-01-08 | Univ Aberdeen | Divergent ultrasound arrays |
DE3545381C2 (en) * | 1985-12-20 | 1994-02-24 | Siemens Ag | Ultrasonic transducer for measuring the sound power of a focused ultrasonic field |
US4983189A (en) * | 1986-02-21 | 1991-01-08 | Technical Research Associates, Inc. | Methods and apparatus for moving and separating materials exhibiting different physical properties |
US4862060A (en) * | 1986-11-18 | 1989-08-29 | Atlantic Richfield Company | Microwave apparatus for measuring fluid mixtures |
US4834124A (en) * | 1987-01-09 | 1989-05-30 | Honda Electronics Co., Ltd. | Ultrasonic cleaning device |
US5037481B1 (en) * | 1987-04-29 | 1993-05-11 | Verteq, Inc. | Megasonic cleaning method |
GB8718756D0 (en) | 1987-08-07 | 1987-09-16 | Unilever Plc | Supporting means |
US4870982A (en) * | 1989-01-09 | 1989-10-03 | Tatung Company Of America, Inc. | Ultrasonic cleaning apparatus for household use |
US4930532A (en) * | 1989-02-17 | 1990-06-05 | Ipco Corporation | Beaker holder for use with ultrasonic cleaning device |
US5026167A (en) * | 1989-10-19 | 1991-06-25 | Heat Systems Incorporated | Ultrasonic fluid processing system |
US5178173A (en) * | 1991-08-01 | 1993-01-12 | Robert J. Pace | Ultrasonic contact lens cleaning device |
ATE144124T1 (en) * | 1991-12-20 | 1996-11-15 | Technomed Medical Systems | DEVICE FOR ULTRASONIC THERAPY EMITTING SOUND WAVES, THERMAL EFFECTS AND CAVITATION EFFECTS |
JPH07113596B2 (en) | 1992-01-16 | 1995-12-06 | 島久薬品株式会社 | Bag for crushing dispersion |
DE4207463C2 (en) * | 1992-03-10 | 1996-03-28 | Siemens Ag | Arrangement for the therapy of tissue with ultrasound |
DE4228618A1 (en) * | 1992-08-28 | 1994-03-03 | Hoechst Ag | Reactor for carrying out chemical reactions |
US5639423A (en) * | 1992-08-31 | 1997-06-17 | The Regents Of The University Of Calfornia | Microfabricated reactor |
JP3429761B2 (en) * | 1992-09-16 | 2003-07-22 | 株式会社 日立製作所 | Ultrasonic irradiation apparatus and processing apparatus using the same |
US5391197A (en) | 1992-11-13 | 1995-02-21 | Dornier Medical Systems, Inc. | Ultrasound thermotherapy probe |
US5876671A (en) * | 1993-03-24 | 1999-03-02 | The Regents Of The University Of California Office Of Technology Transfer | Sonication standard laboratory module |
JP3338520B2 (en) | 1993-07-14 | 2002-10-28 | 島久フードテック株式会社 | Crushing and dispersing bag |
US5395592A (en) * | 1993-10-04 | 1995-03-07 | Bolleman; Brent | Acoustic liquid processing device |
US5409594A (en) * | 1993-11-23 | 1995-04-25 | Dynamotive Corporation | Ultrasonic agitator |
US5368054A (en) | 1993-12-17 | 1994-11-29 | International Business Machines Corporation | Ultrasonic jet semiconductor wafer cleaning apparatus |
US5736100A (en) * | 1994-09-20 | 1998-04-07 | Hitachi, Ltd. | Chemical analyzer non-invasive stirrer |
TW275594B (en) * | 1994-11-14 | 1996-05-11 | Yoshino Denki Kk | Ultrasonic cleaning device |
WO1996022844A1 (en) * | 1995-01-27 | 1996-08-01 | Trustees Of Boston University | Acoustic coaxing methods and apparatus |
US5711327A (en) * | 1995-10-10 | 1998-01-27 | Fields; John T. | System for vibration cleaning of articles including radiators |
US5623095A (en) * | 1995-11-24 | 1997-04-22 | The United States Of America As Represented By The Department Of Energy | Method for chemically analyzing a solution by acoustic means |
US5779985A (en) * | 1995-12-18 | 1998-07-14 | Solid Phase Sciences Corporation | Reaction plenum |
US6277332B1 (en) * | 1995-12-18 | 2001-08-21 | Solid Phase Sciences Corporation | Reaction plenum with magnetic separation and/or ultrasonic agitation |
US6010316A (en) * | 1996-01-16 | 2000-01-04 | The Board Of Trustees Of The Leland Stanford Junior University | Acoustic micropump |
JP2700058B2 (en) | 1996-01-23 | 1998-01-19 | 工業技術院長 | Non-contact micromanipulation method using ultrasonic waves |
US5688406A (en) | 1996-02-28 | 1997-11-18 | The United States Of America As Represented By The Secretary Of The Navy | Method and apparatus for separating particulate from a flowing fluid |
US5631425A (en) | 1996-03-07 | 1997-05-20 | Integrated Device Technology, Inc. | Method for identifying molding compound using an acoustic microscope |
DE19617924A1 (en) | 1996-05-05 | 1997-11-13 | Brace Gmbh Chemie Plastics Dat | Piezoelectric excitation of sprayed fluid close to nozzle exits |
US7211927B2 (en) * | 1996-09-24 | 2007-05-01 | William Puskas | Multi-generator system for an ultrasonic processing tank |
US5890802A (en) * | 1997-02-21 | 1999-04-06 | University Of Washington | Piezo-ceramic actuator-driven mixing device |
US6003388A (en) | 1997-09-17 | 1999-12-21 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | System for manipulating drops and bubbles using acoustic radiation pressure |
US6413783B1 (en) * | 1997-09-18 | 2002-07-02 | Meso Scale Technologies, Llc | Assay sonication apparatus and methodology |
JP2001517789A (en) * | 1997-09-19 | 2001-10-09 | アクレイラ バイオサイエンシズ,インコーポレイティド | Liquid transfer device and liquid transfer method |
US6039309A (en) * | 1997-12-05 | 2000-03-21 | The United States Of America As Represented By The Secretary Of The Navy | Method and apparatus for producing gas bubbles in a liquid medium |
DE19756874A1 (en) * | 1997-12-19 | 1999-06-24 | Basf Ag | Ultrasonic mixing device |
EP1179585B1 (en) * | 1997-12-24 | 2008-07-09 | Cepheid | Device and method for lysis |
US5993671A (en) | 1998-03-18 | 1999-11-30 | Peltzer; Charles T. | Method for manufacturing a system for treating reclaimed water to provide treated water |
US6224778B1 (en) * | 1998-03-18 | 2001-05-01 | Charles T. Peltzer | Method for manufacturing a system for mixing fluids |
DE19820466C2 (en) | 1998-05-07 | 2002-06-13 | Fraunhofer Ges Forschung | Device and method for the targeted exposure of a biological sample to sound waves |
CA2238951A1 (en) * | 1998-05-26 | 1999-11-26 | Les Technologies Sonomax Inc. | Acoustic cavitation reactor for the processing of materials |
JPH11347392A (en) * | 1998-06-11 | 1999-12-21 | Hitachi Ltd | Stirrer |
US6042556A (en) * | 1998-09-04 | 2000-03-28 | University Of Washington | Method for determining phase advancement of transducer elements in high intensity focused ultrasound |
US7687039B2 (en) * | 1998-10-28 | 2010-03-30 | Covaris, Inc. | Methods and systems for modulating acoustic energy delivery |
US6100084A (en) * | 1998-11-05 | 2000-08-08 | The Regents Of The University Of California | Micro-sonicator for spore lysis |
US6855296B1 (en) * | 1998-11-13 | 2005-02-15 | Optime Therapeutics, Inc. | Method and apparatus for liposome production |
EP1146959B1 (en) * | 1998-11-13 | 2008-06-04 | William A. Heriot | Apparatus for liposome production |
US6086821A (en) * | 1999-03-29 | 2000-07-11 | The United States Of America As Represented By The Secretary Of The Navy | Ultrasonic force differentiation assay |
US6210128B1 (en) * | 1999-04-16 | 2001-04-03 | The United States Of America As Represented By The Secretary Of The Navy | Fluidic drive for miniature acoustic fluidic pumps and mixers |
US6291180B1 (en) * | 1999-09-29 | 2001-09-18 | American Registry Of Pathology | Ultrasound-mediated high-speed biological reaction and tissue processing |
EP1128185B8 (en) | 2000-02-25 | 2009-08-19 | Hitachi, Ltd. | Mixing device for automatic analyzer |
US7144729B2 (en) * | 2000-09-01 | 2006-12-05 | Dfb Pharmaceuticals, Inc. | Methods and compositions for tissue regeneration |
US20040054286A1 (en) * | 2001-11-05 | 2004-03-18 | Audain Vaughn A | Ultrasonic transducing probe with liquid flow-through capability and related automated workstation and methods of using same |
US6852463B2 (en) | 2002-03-07 | 2005-02-08 | Seiko Epson Corporation | Apparatus for producing toner, method for producing toner, and toner |
DE10325307B3 (en) | 2003-02-27 | 2004-07-15 | Advalytix Ag | For the mixture of fluids in micro-cavities, in a micro-titration plate, at least one piezo electric sound converter generates an ultrasonic wave to give a wave-induced flow to the fluids |
IL157229A (en) * | 2003-08-04 | 2006-08-20 | Zamir Tribelsky | Method for energy coupling especially useful for disinfecting and various systems using it |
WO2005028635A2 (en) * | 2003-09-19 | 2005-03-31 | Microfluidic Systems Inc. | Microfluidic differential extraction cartridge |
US20050142664A1 (en) * | 2003-12-18 | 2005-06-30 | Affymetrix, Inc. | System, method, and product for mixing fluids in a chamber |
US20050235740A1 (en) * | 2004-04-27 | 2005-10-27 | Guido Desie | Method to improve the quality of dispersion formulations |
JP4469928B2 (en) | 2004-09-22 | 2010-06-02 | ベックマン・コールター・インコーポレーテッド | Stirring vessel |
US7481918B2 (en) * | 2005-04-22 | 2009-01-27 | Siemens Water Technologies Holding Corp. | Vibratory mixer |
US7757561B2 (en) * | 2005-08-01 | 2010-07-20 | Covaris, Inc. | Methods and systems for processing samples using acoustic energy |
US7871016B2 (en) * | 2005-08-26 | 2011-01-18 | Altapure, Llc | Method and apparatus for an improved aerosol generator and associated uses and equipment |
US7780909B2 (en) * | 2006-03-22 | 2010-08-24 | Zimek Technologies Ip, Llc | Ultrasonic sanitation and disinfecting methods |
US8353619B2 (en) | 2006-08-01 | 2013-01-15 | Covaris, Inc. | Methods and apparatus for treating samples with acoustic energy |
US8083864B2 (en) * | 2008-02-22 | 2011-12-27 | Edward Ho | Cleaning device |
-
2007
- 2007-08-01 US US11/888,708 patent/US8353619B2/en active Active
- 2007-08-01 WO PCT/US2007/017281 patent/WO2008016691A2/en active Application Filing
-
2012
- 2012-12-12 US US13/711,807 patent/US20130177922A1/en not_active Abandoned
-
2015
- 2015-09-16 US US14/856,029 patent/US20160002708A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3080299A (en) * | 1960-07-05 | 1963-03-05 | Bendix Corp | Accelerating microorganism physiological activity and reproduction |
US5659173A (en) * | 1994-02-23 | 1997-08-19 | The Regents Of The University Of California | Converting acoustic energy into useful other energy forms |
US20020009015A1 (en) * | 1998-10-28 | 2002-01-24 | Laugharn James A. | Method and apparatus for acoustically controlling liquid solutions in microfluidic devices |
US6719449B1 (en) * | 1998-10-28 | 2004-04-13 | Covaris, Inc. | Apparatus and method for controlling sonic treatment |
Non-Patent Citations (2)
Title |
---|
Bader et al. "The effect of static pressure on the inertial cavitation threshold", J. Acoust. Soc. Am. 132 (2), August 2012, pages 728-737. * |
Barger, James R., Thresholds of Acoustic Cavitation, Acoustics Research Laboratory, Harvard University, April, 1964. * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100132438A1 (en) * | 2008-11-28 | 2010-06-03 | Roche Diagnostics Operations, Inc. | System and method for the automated processing of fluids, method for determining the matching of objects |
US9086396B2 (en) * | 2008-11-28 | 2015-07-21 | Roche Molecular Systems, Inc. | System and method for the automated processing of fluids, method for determining the matching of objects |
US20150276779A1 (en) * | 2008-11-28 | 2015-10-01 | Roche Molecular Systems, Inc. | System and method for the automated processing of fluids, method for determining the matching of objects |
US9377479B2 (en) * | 2008-11-28 | 2016-06-28 | Roche Molecular Systems, Inc. | System and method for the automated processing of fluids, method for determining the matching of objects |
US20140238110A1 (en) * | 2013-02-27 | 2014-08-28 | Ethicon, Inc. | Leakage detection in a medical device |
US9772252B2 (en) * | 2013-02-27 | 2017-09-26 | Ethicon, Inc. | Leakage detection in a medical device |
US9320995B2 (en) | 2013-09-17 | 2016-04-26 | Covaris, Inc. | Method and apparatus for processing sample material |
US20160243488A1 (en) * | 2013-10-14 | 2016-08-25 | Coldharbour Marine Limited | Apparatus and method |
US10765988B2 (en) * | 2013-10-14 | 2020-09-08 | Coldharbour Marine Limited | Apparatus and method for treating gas in a liquid medium with ultrasonic energy for chemical reaction |
WO2019183130A1 (en) * | 2018-03-19 | 2019-09-26 | Trustees Of Boston University | Systems, devices, and methods for ultrasonic agitation mediated kinetic release testing of compounds |
Also Published As
Publication number | Publication date |
---|---|
WO2008016691A2 (en) | 2008-02-07 |
US8353619B2 (en) | 2013-01-15 |
WO2008016691A3 (en) | 2008-06-05 |
US20080031094A1 (en) | 2008-02-07 |
US20160002708A1 (en) | 2016-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8353619B2 (en) | Methods and apparatus for treating samples with acoustic energy | |
US6719449B1 (en) | Apparatus and method for controlling sonic treatment | |
US8263005B2 (en) | Methods and systems for modulating acoustic energy delivery | |
JP5990177B2 (en) | System for acoustically processing materials | |
US7757561B2 (en) | Methods and systems for processing samples using acoustic energy | |
US9918694B2 (en) | Acoustic treatment vessel and method for acoustic treatmet | |
EP2304405B1 (en) | Method and apparatus for treatment enhancement in acoustic processing of samples | |
US8702836B2 (en) | Methods and apparatus for treating samples with acoustic energy to form particles and particulates | |
US9320995B2 (en) | Method and apparatus for processing sample material | |
EP2732078B1 (en) | Methods for preparing nanocrystalline compositions using focused acoustics | |
US11092521B2 (en) | Method and system for acoustically treating material | |
US10058860B2 (en) | Methods and apparatuses for acoustic treatment of samples | |
EP2532433A1 (en) | Device for fragmenting molecules in a sample by ultrasound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: COVARIS, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LAUGHARN, JAMES A., JR.;GARRISON, BREVARD S.;YATES, DOUGLAS A.;REEL/FRAME:029949/0593 Effective date: 20071019 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: COVARIS, LLC, MASSACHUSETTS Free format text: CHANGE OF NAME;ASSIGNOR:COVARIS, INC.;REEL/FRAME:058768/0261 Effective date: 20211228 |